-
1
-
-
0033551387
-
Mechanisms of apoptosis by c-Myc
-
10378693
-
Prendergast GC. Mechanisms of apoptosis by c-Myc. Oncogene. 1999;18(19):2967-87.
-
(1999)
Oncogene
, vol.18
, Issue.19
, pp. 2967-2987
-
-
Prendergast, G.C.1
-
2
-
-
56749184298
-
Reflecting on 25 years with MYC
-
19029958
-
Meyer N, Penn LZ. Reflecting on 25 years with MYC. Nat Rev Cancer. 2008;8(12):976-90.
-
(2008)
Nat Rev Cancer
, vol.8
, Issue.12
, pp. 976-990
-
-
Meyer, N.1
Penn, L.Z.2
-
5
-
-
0029864934
-
Discrimination between different E-box-binding proteins at an endogenous target gene of c-myc
-
8600028
-
Desbarats L, Gaubatz S, Eilers M. Discrimination between different E-box-binding proteins at an endogenous target gene of c-myc. Genes Dev. 1996;10(4):447-60.
-
(1996)
Genes Dev
, vol.10
, Issue.4
, pp. 447-460
-
-
Desbarats, L.1
Gaubatz, S.2
Eilers, M.3
-
6
-
-
0030762087
-
C-Myc/Max heterodimers bind cooperatively to the E-box sequences located in the first intron of the rat ornithine decarboxylase (ODC) gene
-
9162900 146624
-
Walhout AJ, Gubbels JM, Bernards R, van der Vliet PC, Timmers HT. c-Myc/Max heterodimers bind cooperatively to the E-box sequences located in the first intron of the rat ornithine decarboxylase (ODC) gene. Nucleic Acids Res. 1997;25(8):1493-501.
-
(1997)
Nucleic Acids Res
, vol.25
, Issue.8
, pp. 1493-1501
-
-
Walhout, A.J.1
Gubbels, J.M.2
Bernards, R.3
Van Der Vliet, P.C.4
Timmers, H.T.5
-
7
-
-
0000538165
-
Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells
-
6961453 347441
-
Dalla-Favera R, Bregni M, Erikson J, Patterson D, Gallo RC, Croce CM. Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc Natl Acad Sci U S A. 1982;79(24):7824-7.
-
(1982)
Proc Natl Acad Sci U S A
, vol.79
, Issue.24
, pp. 7824-7827
-
-
Dalla-Favera, R.1
Bregni, M.2
Erikson, J.3
Patterson, D.4
Gallo, R.C.5
Croce, C.M.6
-
8
-
-
0001292985
-
Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells
-
6818551 347444
-
Taub R, Kirsch I, Morton C, Lenoir G, Swan D, Tronick S, Aaronson S, Leder P. Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells. Proc Natl Acad Sci U S A. 1982;79(24):7837-41.
-
(1982)
Proc Natl Acad Sci U S A
, vol.79
, Issue.24
, pp. 7837-7841
-
-
Taub, R.1
Kirsch, I.2
Morton, C.3
Lenoir, G.4
Swan, D.5
Tronick, S.6
Aaronson, S.7
Leder, P.8
-
9
-
-
0022380768
-
The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice
-
3906410
-
Adams JM, Harris AW, Pinkert CA, Corcoran LM, Alexander WS, Cory S, Palmiter RD, Brinster RL. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature. 1985;318(6046):533-8.
-
(1985)
Nature
, vol.318
, Issue.6046
, pp. 533-538
-
-
Adams, J.M.1
Harris, A.W.2
Pinkert, C.A.3
Corcoran, L.M.4
Alexander, W.S.5
Cory, S.6
Palmiter, R.D.7
Brinster, R.L.8
-
10
-
-
33748171960
-
The c-Myc target gene network
-
16904903
-
Dang CV, O'Donnell KA, Zeller KI, Nguyen T, Osthus RC, Li F. The c-Myc target gene network. Semin Cancer Biol. 2006;16(4):253-64.
-
(2006)
Semin Cancer Biol
, vol.16
, Issue.4
, pp. 253-264
-
-
Dang, C.V.1
O'Donnell, K.A.2
Zeller, K.I.3
Nguyen, T.4
Osthus, R.C.5
Li, F.6
-
11
-
-
84859171807
-
MYC on the path to cancer
-
22464321 3345192
-
Dang CV. MYC on the path to cancer. Cell. 2012;149(1):22-35.
-
(2012)
Cell
, vol.149
, Issue.1
, pp. 22-35
-
-
Dang, C.V.1
-
12
-
-
85050763688
-
Targeting oncogenic Myc as a strategy for cancer treatment
-
29527331 5837124
-
Chen H, Liu H, Qing G. Targeting oncogenic Myc as a strategy for cancer treatment. Signal Transduct Target Ther. 2018;3:5.
-
(2018)
Signal Transduct Target Ther
, vol.3
, pp. 5
-
-
Chen, H.1
Liu, H.2
Qing, G.3
-
13
-
-
84978513097
-
Clinical and Biologic Significance of MYC Genetic Mutations in de Novo Diffuse Large B-cell Lymphoma
-
26927665 4947447
-
Xu-Monette ZY, Deng Q, Manyam GC, Tzankov A, Li L, Xia Y, Wang XX, Zou D, Visco C, Dybkaer K, et al. Clinical and Biologic Significance of MYC Genetic Mutations in De Novo Diffuse Large B-cell Lymphoma. Clin Cancer Res. 2016;22(14):3593-3605.
-
(2016)
Clin Cancer Res
, vol.22
, Issue.14
, pp. 3593-3605
-
-
Xu-Monette, Z.Y.1
Deng, Q.2
Manyam, G.C.3
Tzankov, A.4
Li, L.5
Xia, Y.6
Wang, X.X.7
Zou, D.8
Visco, C.9
Dybkaer, K.10
-
14
-
-
85019688331
-
Genetic profiling of MYC and BCL2 in diffuse large B-cell lymphoma determines cell-of-origin-specific clinical impact
-
28351934
-
Ennishi D, Mottok A, Ben-Neriah S, Shulha HP, Farinha P, Chan FC, Meissner B, Boyle M, Hother C, Kridel R, et al. Genetic profiling of MYC and BCL2 in diffuse large B-cell lymphoma determines cell-of-origin-specific clinical impact. Blood. 2017;129(20):2760-2770.
-
(2017)
Blood
, vol.129
, Issue.20
, pp. 2760-2770
-
-
Ennishi, D.1
Mottok, A.2
Ben-Neriah, S.3
Shulha, H.P.4
Farinha, P.5
Chan, F.C.6
Meissner, B.7
Boyle, M.8
Hother, C.9
Kridel, R.10
-
15
-
-
79952841250
-
MYC and Breast Cancer
-
21779462 3092228
-
Xu J, Chen Y, Olopade OI. MYC and Breast Cancer. Genes Cancer. 2010;1(6):629-40.
-
(2010)
Genes Cancer
, vol.1
, Issue.6
, pp. 629-640
-
-
Xu, J.1
Chen, Y.2
Olopade, O.I.3
-
16
-
-
85044336302
-
Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas
-
e282
-
Schaub FX, Dhankani V, Berger AC, Trivedi M, Richardson AB, Shaw R, Zhao W, Zhang X, Ventura A, Liu Y, et al. Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas. Cell Syst. 2018;6(3):282-300 e282.
-
(2018)
Cell Syst.
, vol.6
, Issue.3
, pp. 282-300
-
-
Schaub, F.X.1
Dhankani, V.2
Berger, A.C.3
Trivedi, M.4
Richardson, A.B.5
Shaw, R.6
Zhao, W.7
Zhang, X.8
Ventura, A.9
Liu, Y.10
-
18
-
-
0035904463
-
Function and regulation of the transcription factors of the Myc/Max/Mad network
-
11602341
-
Luscher B. Function and regulation of the transcription factors of the Myc/Max/Mad network. Gene. 2001;277(1-2):1-14.
-
(2001)
Gene
, vol.277
, Issue.1-2
, pp. 1-14
-
-
Luscher, B.1
-
19
-
-
0027315650
-
A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice
-
8458579
-
Davis AC, Wims M, Spotts GD, Hann SR, Bradley A. A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice. Genes Dev. 1993;7(4):671-82.
-
(1993)
Genes Dev
, vol.7
, Issue.4
, pp. 671-682
-
-
Davis, A.C.1
Wims, M.2
Spotts, G.D.3
Hann, S.R.4
Bradley, A.5
-
20
-
-
0027080193
-
Embryonic lethality in mice homozygous for a targeted disruption of the N-myc gene
-
1459450
-
Charron J, Malynn BA, Fisher P, Stewart V, Jeannotte L, Goff SP, Robertson EJ, Alt FW. Embryonic lethality in mice homozygous for a targeted disruption of the N-myc gene. Genes Dev. 1992;6(12A):2248-57.
-
(1992)
Genes Dev
, vol.6
, Issue.12 A
, pp. 2248-2257
-
-
Charron, J.1
Malynn, B.A.2
Fisher, P.3
Stewart, V.4
Jeannotte, L.5
Goff, S.P.6
Robertson, E.J.7
Alt, F.W.8
-
21
-
-
0026628060
-
A targeted mutation reveals a role for N-myc in branching morphogenesis in the embryonic mouse lung
-
1577267
-
Moens CB, Auerbach AB, Conlon RA, Joyner AL, Rossant J. A targeted mutation reveals a role for N-myc in branching morphogenesis in the embryonic mouse lung. Genes Dev. 1992;6(5):691-704.
-
(1992)
Genes Dev
, vol.6
, Issue.5
, pp. 691-704
-
-
Moens, C.B.1
Auerbach, A.B.2
Conlon, R.A.3
Joyner, A.L.4
Rossant, J.5
-
22
-
-
0027066738
-
Loss of N-myc function results in embryonic lethality and failure of the epithelial component of the embryo to develop
-
1459449
-
Stanton BR, Perkins AS, Tessarollo L, Sassoon DA, Parada LF. Loss of N-myc function results in embryonic lethality and failure of the epithelial component of the embryo to develop. Genes Dev. 1992;6(12A):2235-47.
-
(1992)
Genes Dev
, vol.6
, Issue.12 A
, pp. 2235-2247
-
-
Stanton, B.R.1
Perkins, A.S.2
Tessarollo, L.3
Sassoon, D.A.4
Parada, L.F.5
-
23
-
-
0037108268
-
N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation
-
12381668 187459
-
Knoepfler PS, Cheng PF, Eisenman RN. N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation. Genes Dev. 2002;16(20):2699-712.
-
(2002)
Genes Dev
, vol.16
, Issue.20
, pp. 2699-2712
-
-
Knoepfler, P.S.1
Cheng, P.F.2
Eisenman, R.N.3
-
24
-
-
0029981848
-
Expression and activity of L-Myc in normal mouse development
-
8657155 231166
-
Hatton KS, Mahon K, Chin L, Chiu FC, Lee HW, Peng D, Morgenbesser SD, Horner J, DePinho RA. Expression and activity of L-Myc in normal mouse development. Mol Cell Biol. 1996;16(4):1794-804.
-
(1996)
Mol Cell Biol
, vol.16
, Issue.4
, pp. 1794-1804
-
-
Hatton, K.S.1
Mahon, K.2
Chin, L.3
Chiu, F.C.4
Lee, H.W.5
Peng, D.6
Morgenbesser, S.D.7
Horner, J.8
Depinho, R.A.9
-
25
-
-
84883759641
-
Control of vertebrate development by MYC
-
24003246 3753724
-
Hurlin PJ. Control of vertebrate development by MYC. Cold Spring Harb Perspect Med. 2013;3(9):a014332.
-
(2013)
Cold Spring Harb Perspect Med
, vol.3
, Issue.9
, pp. a014332
-
-
Hurlin, P.J.1
-
26
-
-
77954142510
-
Myc maintains embryonic stem cell pluripotency and self-renewal
-
20537458 2916696
-
Varlakhanova NV, Cotterman RF, deVries WN, Morgan J, Donahue LR, Murray S, Knowles BB, Knoepfler PS. myc maintains embryonic stem cell pluripotency and self-renewal. Differentiation. 2010;80(1):9-19.
-
(2010)
Differentiation
, vol.80
, Issue.1
, pp. 9-19
-
-
Varlakhanova, N.V.1
Cotterman, R.F.2
Devries, W.N.3
Morgan, J.4
Donahue, L.R.5
Murray, S.6
Knowles, B.B.7
Knoepfler, P.S.8
-
27
-
-
76749119582
-
Single-cell transcript analysis of human embryonic stem cells
-
Gibson JD, Jakuba CM, Boucher N, Holbrook KA, Carter MG, Nelson CE. Single-cell transcript analysis of human embryonic stem cells. Integr Biol (Camb). 2009;1(8-9):540-51.
-
(2009)
Integr Biol (Camb)
, vol.1
, Issue.8-9
, pp. 540-551
-
-
Gibson, J.D.1
Jakuba, C.M.2
Boucher, N.3
Holbrook, K.A.4
Carter, M.G.5
Nelson, C.E.6
-
28
-
-
58249085824
-
Role of the murine reprogramming factors in the induction of pluripotency
-
19167336 3273494
-
Sridharan R, Tchieu J, Mason MJ, Yachechko R, Kuoy E, Horvath S, Zhou Q, Plath K. Role of the murine reprogramming factors in the induction of pluripotency. Cell. 2009;136(2):364-77.
-
(2009)
Cell
, vol.136
, Issue.2
, pp. 364-377
-
-
Sridharan, R.1
Tchieu, J.2
Mason, M.J.3
Yachechko, R.4
Kuoy, E.5
Horvath, S.6
Zhou, Q.7
Plath, K.8
-
29
-
-
16844364151
-
LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism
-
15673569
-
Cartwright P, McLean C, Sheppard A, Rivett D, Jones K, Dalton S. LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism. Development. 2005;132(5):885-96.
-
(2005)
Development
, vol.132
, Issue.5
, pp. 885-896
-
-
Cartwright, P.1
McLean, C.2
Sheppard, A.3
Rivett, D.4
Jones, K.5
Dalton, S.6
-
30
-
-
79960030545
-
Indefinite self-renewal of ESCs through Myc/Max transcriptional complex-independent mechanisms
-
21726832
-
Hishida T, Nozaki Y, Nakachi Y, Mizuno Y, Okazaki Y, Ema M, Takahashi S, Nishimoto M, Okuda A. Indefinite self-renewal of ESCs through Myc/Max transcriptional complex-independent mechanisms. Cell Stem Cell. 2011;9(1):37-49.
-
(2011)
Cell Stem Cell
, vol.9
, Issue.1
, pp. 37-49
-
-
Hishida, T.1
Nozaki, Y.2
Nakachi, Y.3
Mizuno, Y.4
Okazaki, Y.5
Ema, M.6
Takahashi, S.7
Nishimoto, M.8
Okuda, A.9
-
31
-
-
33744917003
-
Phosphorylation regulates Myc expression via prolonged activation of the mitogen-activated protein kinase pathway
-
16596619
-
Wang Z, Ge L, Wang M, Carr BI. Phosphorylation regulates Myc expression via prolonged activation of the mitogen-activated protein kinase pathway. J Cell Physiol. 2006;208(1):133-40.
-
(2006)
J Cell Physiol
, vol.208
, Issue.1
, pp. 133-140
-
-
Wang, Z.1
Ge, L.2
Wang, M.3
Carr, B.I.4
-
32
-
-
77956214711
-
Myc represses primitive endoderm differentiation in pluripotent stem cells
-
20804970 2954754
-
Smith KN, Singh AM, Dalton S. Myc represses primitive endoderm differentiation in pluripotent stem cells. Cell Stem Cell. 2010;7(3):343-54.
-
(2010)
Cell Stem Cell
, vol.7
, Issue.3
, pp. 343-354
-
-
Smith, K.N.1
Singh, A.M.2
Dalton, S.3
-
33
-
-
84958212407
-
Myc Depletion Induces a Pluripotent Dormant State Mimicking Diapause
-
Scognamiglio R, Cabezas-Wallscheid N, Thier MC, Altamura S, Reyes A, Prendergast AM, Baumgartner D, Carnevalli LS, Atzberger A, Haas S, et al. Myc Depletion Induces a Pluripotent Dormant State Mimicking Diapause. Cell. 2016;164(4):668-680.
-
(2016)
Cell
, vol.164
, Issue.4
, pp. 668-680
-
-
Scognamiglio, R.1
Cabezas-Wallscheid, N.2
Thier, M.C.3
Altamura, S.4
Reyes, A.5
Prendergast, A.M.6
Baumgartner, D.7
Carnevalli, L.S.8
Atzberger, A.9
Haas, S.10
-
34
-
-
0033569429
-
Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF
-
10541554 317101
-
Jacobs JJ, Scheijen B, Voncken JW, Kieboom K, Berns A, van Lohuizen M. Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF. Genes Dev. 1999;13(20):2678-90.
-
(1999)
Genes Dev
, vol.13
, Issue.20
, pp. 2678-2690
-
-
Jacobs, J.J.1
Scheijen, B.2
Voncken, J.W.3
Kieboom, K.4
Berns, A.5
Van Lohuizen, M.6
-
35
-
-
84873320012
-
A positive feedback loop regulates the expression of polycomb group protein BMI1 via WNT signaling pathway
-
23239878
-
Cho JH, Dimri M, Dimri GP. A positive feedback loop regulates the expression of polycomb group protein BMI1 via WNT signaling pathway. J Biol Chem. 2013;288(5):3406-18.
-
(2013)
J Biol Chem
, vol.288
, Issue.5
, pp. 3406-3418
-
-
Cho, J.H.1
Dimri, M.2
Dimri, G.P.3
-
36
-
-
84978096840
-
Bmi-1: At the crossroads of physiological and pathological biology
-
26448339 4593320
-
Bhattacharya R, Mustafi SB, Street M, Dey A, Dwivedi SK. Bmi-1: At the crossroads of physiological and pathological biology. Genes Dis. 2015;2(3):225-39.
-
(2015)
Genes Dis
, vol.2
, Issue.3
, pp. 225-239
-
-
Bhattacharya, R.1
Mustafi, S.B.2
Street, M.3
Dey, A.4
Dwivedi, S.K.5
-
37
-
-
33747195353
-
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors
-
16904174
-
Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663-76.
-
(2006)
Cell
, vol.126
, Issue.4
, pp. 663-676
-
-
Takahashi, K.1
Yamanaka, S.2
-
38
-
-
34249880066
-
Generation of germline-competent induced pluripotent stem cells
-
17554338
-
Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature. 2007;448(7151):313-7.
-
(2007)
Nature
, vol.448
, Issue.7151
, pp. 313-317
-
-
Okita, K.1
Ichisaka, T.2
Yamanaka, S.3
-
39
-
-
34249908901
-
In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state
-
17554336
-
Wernig M, Meissner A, Foreman R, Brambrink T, Ku M, Hochedlinger K, Bernstein BE, Jaenisch R. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature. 2007;448(7151):318-24.
-
(2007)
Nature
, vol.448
, Issue.7151
, pp. 318-324
-
-
Wernig, M.1
Meissner, A.2
Foreman, R.3
Brambrink, T.4
Ku, M.5
Hochedlinger, K.6
Bernstein, B.E.7
Jaenisch, R.8
-
40
-
-
70349675629
-
IPS programmed without c-MYC yield proficient cardiogenesis for functional heart chimerism
-
19696409 2785796
-
Martinez-Fernandez A, Nelson TJ, Yamada S, Reyes S, Alekseev AE, Perez-Terzic C, Ikeda Y, Terzic A. iPS programmed without c-MYC yield proficient cardiogenesis for functional heart chimerism. Circ Res. 2009;105(7):648-56.
-
(2009)
Circ Res
, vol.105
, Issue.7
, pp. 648-656
-
-
Martinez-Fernandez, A.1
Nelson, T.J.2
Yamada, S.3
Reyes, S.4
Alekseev, A.E.5
Perez-Terzic, C.6
Ikeda, Y.7
Terzic, A.8
-
41
-
-
77956278519
-
Promotion of direct reprogramming by transformation-deficient Myc
-
20660764 2922531
-
Nakagawa M, Takizawa N, Narita M, Ichisaka T, Yamanaka S. Promotion of direct reprogramming by transformation-deficient Myc. Proc Natl Acad Sci U S A. 2010;107(32):14152-7.
-
(2010)
Proc Natl Acad Sci U S A
, vol.107
, Issue.32
, pp. 14152-14157
-
-
Nakagawa, M.1
Takizawa, N.2
Narita, M.3
Ichisaka, T.4
Yamanaka, S.5
-
42
-
-
38049028459
-
Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts
-
18059259
-
Nakagawa M, Koyanagi M, Tanabe K, Takahashi K, Ichisaka T, Aoi T, Okita K, Mochiduki Y, Takizawa N, Yamanaka S. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol. 2008;26(1):101-6.
-
(2008)
Nat Biotechnol
, vol.26
, Issue.1
, pp. 101-106
-
-
Nakagawa, M.1
Koyanagi, M.2
Tanabe, K.3
Takahashi, K.4
Ichisaka, T.5
Aoi, T.6
Okita, K.7
Mochiduki, Y.8
Takizawa, N.9
Yamanaka, S.10
-
43
-
-
55849117368
-
Generation of mouse induced pluripotent stem cells without viral vectors
-
18845712
-
Okita K, Nakagawa M, Hyenjong H, Ichisaka T, Yamanaka S. Generation of mouse induced pluripotent stem cells without viral vectors. Science. 2008;322(5903):949-53.
-
(2008)
Science
, vol.322
, Issue.5903
, pp. 949-953
-
-
Okita, K.1
Nakagawa, M.2
Hyenjong, H.3
Ichisaka, T.4
Yamanaka, S.5
-
44
-
-
55849115999
-
Induced pluripotent stem cells generated without viral integration
-
18818365 3987909
-
Stadtfeld M, Nagaya M, Utikal J, Weir G, Hochedlinger K. Induced pluripotent stem cells generated without viral integration. Science. 2008;322(5903):945-9.
-
(2008)
Science
, vol.322
, Issue.5903
, pp. 945-949
-
-
Stadtfeld, M.1
Nagaya, M.2
Utikal, J.3
Weir, G.4
Hochedlinger, K.5
-
45
-
-
65649116572
-
Human induced pluripotent stem cells free of vector and transgene sequences
-
19325077 2758053
-
Yu J, Hu K, Smuga-Otto K, Tian S, Stewart R, Slukvin II, Thomson JA. Human induced pluripotent stem cells free of vector and transgene sequences. Science. 2009;324(5928):797-801.
-
(2009)
Science
, vol.324
, Issue.5928
, pp. 797-801
-
-
Yu, J.1
Hu, K.2
Smuga-Otto, K.3
Tian, S.4
Stewart, R.5
Slukvin, I.I.6
Thomson, J.A.7
-
46
-
-
65449154892
-
Generation of transgene-free induced pluripotent mouse stem cells by the piggyBac transposon
-
19337237 2677165
-
Yusa K, Rad R, Takeda J, Bradley A. Generation of transgene-free induced pluripotent mouse stem cells by the piggyBac transposon. Nat Methods. 2009;6(5):363-9.
-
(2009)
Nat Methods
, vol.6
, Issue.5
, pp. 363-369
-
-
Yusa, K.1
Rad, R.2
Takeda, J.3
Bradley, A.4
-
47
-
-
0024027330
-
L-myc cooperates with ras to transform primary rat embryo fibroblasts
-
2457153 363472
-
Birrer MJ, Segal S, DeGreve JS, Kaye F, Sausville EA, Minna JD. L-myc cooperates with ras to transform primary rat embryo fibroblasts. Mol Cell Biol. 1988;8(6):2668-73.
-
(1988)
Mol Cell Biol
, vol.8
, Issue.6
, pp. 2668-2673
-
-
Birrer, M.J.1
Segal, S.2
Degreve, J.S.3
Kaye, F.4
Sausville, E.A.5
Minna, J.D.6
-
48
-
-
0037417130
-
Functional analysis of the N-terminal domain of the Myc oncoprotein
-
12673205
-
Oster SK, Mao DY, Kennedy J, Penn LZ. Functional analysis of the N-terminal domain of the Myc oncoprotein. Oncogene. 2003;22(13):1998-2010.
-
(2003)
Oncogene
, vol.22
, Issue.13
, pp. 1998-2010
-
-
Oster, S.K.1
Mao, D.Y.2
Kennedy, J.3
Penn, L.Z.4
-
49
-
-
52449101436
-
Transcription-independent functions of MYC: Regulation of translation and DNA replication
-
18698328
-
Cole MD, Cowling VH. Transcription-independent functions of MYC: regulation of translation and DNA replication. Nat Rev Mol Cell Biol. 2008;9(10):810-5.
-
(2008)
Nat Rev Mol Cell Biol
, vol.9
, Issue.10
, pp. 810-815
-
-
Cole, M.D.1
Cowling, V.H.2
-
50
-
-
0018182764
-
Identification of nucleotide sequences which may encode the oncogenic capacity of avian retrovirus MC29
-
214581 354308
-
Sheiness D, Fanshier L, Bishop JM. Identification of nucleotide sequences which may encode the oncogenic capacity of avian retrovirus MC29. J Virol. 1978;28(2):600-10.
-
(1978)
J Virol
, vol.28
, Issue.2
, pp. 600-610
-
-
Sheiness, D.1
Fanshier, L.2
Bishop, J.M.3
-
51
-
-
85044003494
-
MYC-driven epigenetic reprogramming favors the onset of tumorigenesis by inducing a stem cell-like state
-
Poli V, Fagnocchi L, Fasciani A, Cherubini A, Mazzoleni S, Ferrillo S, Miluzio A, Gaudioso G, Vaira V, Turdo A, et al. MYC-driven epigenetic reprogramming favors the onset of tumorigenesis by inducing a stem cell-like state. Nat Commun. 2018;9(1):1024.
-
(2018)
Nat Commun.
, vol.9
, Issue.1
, pp. 1024
-
-
Poli, V.1
Fagnocchi, L.2
Fasciani, A.3
Cherubini, A.4
Mazzoleni, S.5
Ferrillo, S.6
Miluzio, A.7
Gaudioso, G.8
Vaira, V.9
Turdo, A.10
-
52
-
-
85045907266
-
Enhancer reprogramming in tumor progression: A new route towards cancer cell plasticity
-
29691590
-
Fagnocchi L, Poli V, Zippo A. Enhancer reprogramming in tumor progression: a new route towards cancer cell plasticity. Cell Mol Life Sci. 2018;75(14):2537-2555.
-
(2018)
Cell Mol Life Sci
, vol.75
, Issue.14
, pp. 2537-2555
-
-
Fagnocchi, L.1
Poli, V.2
Zippo, A.3
-
53
-
-
0842309106
-
MYCN in neuronal tumours
-
15013217
-
Schwab M. MYCN in neuronal tumours. Cancer Lett. 2004;204(2):179-87.
-
(2004)
Cancer Lett
, vol.204
, Issue.2
, pp. 179-187
-
-
Schwab, M.1
-
54
-
-
84962090106
-
N-Myc Drives Neuroendocrine Prostate Cancer Initiated from Human Prostate Epithelial Cells
-
Lee JK, Phillips JW, Smith BA, Park JW, Stoyanova T, McCaffrey EF, Baertsch R, Sokolov A, Meyerowitz JG, Mathis C, et al. N-Myc Drives Neuroendocrine Prostate Cancer Initiated from Human Prostate Epithelial Cells. Cancer Cell. 2016;29(4):536-547.
-
(2016)
Cancer Cell
, vol.29
, Issue.4
, pp. 536-547
-
-
Lee, J.K.1
Phillips, J.W.2
Smith, B.A.3
Park, J.W.4
Stoyanova, T.5
McCaffrey, E.F.6
Baertsch, R.7
Sokolov, A.8
Meyerowitz, J.G.9
Mathis, C.10
-
55
-
-
85041428603
-
The Expanding World of N-MYC-Driven Tumors
-
29358508
-
Rickman DS, Schulte JH, Eilers M. The Expanding World of N-MYC-Driven Tumors. Cancer Discov. 2018;8(2):150-63.
-
(2018)
Cancer Discov
, vol.8
, Issue.2
, pp. 150-163
-
-
Rickman, D.S.1
Schulte, J.H.2
Eilers, M.3
-
56
-
-
84877933549
-
MYCN: From oncoprotein to tumor-associated antigen
-
23162796 3499703
-
Pistoia V, Morandi F, Pezzolo A, Raffaghello L, Prigione I. MYCN: from oncoprotein to tumor-associated antigen. Front Oncol. 2012;2:174.
-
(2012)
Front Oncol
, vol.2
, pp. 174
-
-
Pistoia, V.1
Morandi, F.2
Pezzolo, A.3
Raffaghello, L.4
Prigione, I.5
-
57
-
-
85020278745
-
Biology and evolution of poorly differentiated neuroendocrine tumors
-
28586335
-
Rickman DS, Beltran H, Demichelis F, Rubin MA. Biology and evolution of poorly differentiated neuroendocrine tumors. Nat Med. 2017;23(6):1-10.
-
(2017)
Nat Med
, vol.23
, Issue.6
, pp. 1-10
-
-
Rickman, D.S.1
Beltran, H.2
Demichelis, F.3
Rubin, M.A.4
-
58
-
-
84991790827
-
N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer
-
Dardenne E, Beltran H, Benelli M, Gayvert K, Berger A, Puca L, Cyrta J, Sboner A, Noorzad Z, MacDonald T, et al. N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer. Cancer Cell. 2016;30(4):563-577.
-
(2016)
Cancer Cell
, vol.30
, Issue.4
, pp. 563-577
-
-
Dardenne, E.1
Beltran, H.2
Benelli, M.3
Gayvert, K.4
Berger, A.5
Puca, L.6
Cyrta, J.7
Sboner, A.8
Noorzad, Z.9
Macdonald, T.10
-
59
-
-
84905244381
-
Regulation and Role of EZH2 in Cancer
-
25038756 4132442
-
Yamaguchi H, Hung MC. Regulation and Role of EZH2 in Cancer. Cancer Res Treat. 2014;46(3):209-22.
-
(2014)
Cancer Res Treat
, vol.46
, Issue.3
, pp. 209-222
-
-
Yamaguchi, H.1
Hung, M.C.2
-
60
-
-
0009483251
-
Human small-cell lung cancers show amplification and expression of the N-myc gene
-
2869482 323017
-
Nau MM, Brooks BJ Jr, Carney DN, Gazdar AF, Battey JF, Sausville EA, Minna JD. Human small-cell lung cancers show amplification and expression of the N-myc gene. Proc Natl Acad Sci U S A. 1986;83(4):1092-6.
-
(1986)
Proc Natl Acad Sci U S A
, vol.83
, Issue.4
, pp. 1092-1096
-
-
Nau, M.M.1
Brooks, B.J.2
Carney, D.N.3
Gazdar, A.F.4
Battey, J.F.5
Sausville, E.A.6
Minna, J.D.7
-
61
-
-
0022462112
-
Gene amplification of c-myc and N-myc in small cell carcinoma of the lung
-
3014659
-
Wong AJ, Ruppert JM, Eggleston J, Hamilton SR, Baylin SB, Vogelstein B. Gene amplification of c-myc and N-myc in small cell carcinoma of the lung. Science. 1986;233(4762):461-4.
-
(1986)
Science
, vol.233
, Issue.4762
, pp. 461-464
-
-
Wong, A.J.1
Ruppert, J.M.2
Eggleston, J.3
Hamilton, S.R.4
Baylin, S.B.5
Vogelstein, B.6
-
62
-
-
0023263664
-
Increased expression of N-myc in human small cell lung cancer biopsies predicts lack of response to chemotherapy and poor prognosis
-
3039835
-
Funa K, Steinholtz L, Nou E, Bergh J. Increased expression of N-myc in human small cell lung cancer biopsies predicts lack of response to chemotherapy and poor prognosis. Am J Clin Pathol. 1987;88(2):216-20.
-
(1987)
Am J Clin Pathol
, vol.88
, Issue.2
, pp. 216-220
-
-
Funa, K.1
Steinholtz, L.2
Nou, E.3
Bergh, J.4
-
63
-
-
0031049728
-
N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: Results of the French NBL 90 study. Neuroblastoma Study Group of the Societe Francaise d'Oncologie Pediatrique
-
Rubie H, Hartmann O, Michon J, Frappaz D, Coze C, Chastagner P, Baranzelli MC, Plantaz D, Avet-Loiseau H, Benard J, et al. N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Societe Francaise d'Oncologie Pediatrique. J Clin Oncol. 1997;15(3):1171-1182.
-
(1997)
J Clin Oncol
, vol.15
, Issue.3
, pp. 1171-1182
-
-
Rubie, H.1
Hartmann, O.2
Michon, J.3
Frappaz, D.4
Coze, C.5
Chastagner, P.6
Baranzelli, M.C.7
Plantaz, D.8
Avet-Loiseau, H.9
Benard, J.10
-
64
-
-
84860168795
-
Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets
-
22389870 3290518
-
Beltran H, Rickman DS, Park K, Chae SS, Sboner A, MacDonald TY, Wang Y, Sheikh KL, Terry S, Tagawa ST, et al. Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets. Cancer Discov. 2011;1(6):487-95.
-
(2011)
Cancer Discov
, vol.1
, Issue.6
, pp. 487-495
-
-
Beltran, H.1
Rickman, D.S.2
Park, K.3
Chae, S.S.4
Sboner, A.5
Macdonald, T.Y.6
Wang, Y.7
Sheikh, K.L.8
Terry, S.9
Tagawa, S.T.10
-
65
-
-
84873048485
-
Concurrent AURKA and MYCN gene amplifications are harbingers of lethal treatment-related neuroendocrine prostate cancer
-
23358695 3556934
-
Mosquera JM, Beltran H, Park K, MacDonald TY, Robinson BD, Tagawa ST, Perner S, Bismar TA, Erbersdobler A, Dhir R, et al. Concurrent AURKA and MYCN gene amplifications are harbingers of lethal treatment-related neuroendocrine prostate cancer. Neoplasia. 2013;15(1):1-10.
-
(2013)
Neoplasia
, vol.15
, Issue.1
, pp. 1-10
-
-
Mosquera, J.M.1
Beltran, H.2
Park, K.3
Macdonald, T.Y.4
Robinson, B.D.5
Tagawa, S.T.6
Perner, S.7
Bismar, T.A.8
Erbersdobler, A.9
Dhir, R.10
-
66
-
-
63749118521
-
Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci
-
19255330
-
Pfister S, Remke M, Benner A, Mendrzyk F, Toedt G, Felsberg J, Wittmann A, Devens F, Gerber NU, Joos S, et al. Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci. J Clin Oncol. 2009;27(10):1627-36.
-
(2009)
J Clin Oncol
, vol.27
, Issue.10
, pp. 1627-1636
-
-
Pfister, S.1
Remke, M.2
Benner, A.3
Mendrzyk, F.4
Toedt, G.5
Felsberg, J.6
Wittmann, A.7
Devens, F.8
Gerber, N.U.9
Joos, S.10
-
67
-
-
85009505564
-
MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition
-
28089889 5310991
-
Mollaoglu G, Guthrie MR, Bohm S, Bragelmann J, Can I, Ballieu PM, Marx A, George J, Heinen C, Chalishazar MD, et al. MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition. Cancer Cell. 2017;31(2):270-85.
-
(2017)
Cancer Cell
, vol.31
, Issue.2
, pp. 270-285
-
-
Mollaoglu, G.1
Guthrie, M.R.2
Bohm, S.3
Bragelmann, J.4
Can, I.5
Ballieu, P.M.6
Marx, A.7
George, J.8
Heinen, C.9
Chalishazar, M.D.10
-
68
-
-
84876205922
-
NeuroD1 regulates survival and migration of neuroendocrine lung carcinomas via signaling molecules TrkB and NCAM
-
23553831 3631659
-
Osborne JK, Larsen JE, Shields MD, Gonzales JX, Shames DS, Sato M, Kulkarni A, Wistuba II, Girard L, Minna JD, et al. NeuroD1 regulates survival and migration of neuroendocrine lung carcinomas via signaling molecules TrkB and NCAM. Proc Natl Acad Sci U S A. 2013;110(16):6524-9.
-
(2013)
Proc Natl Acad Sci U S A
, vol.110
, Issue.16
, pp. 6524-6529
-
-
Osborne, J.K.1
Larsen, J.E.2
Shields, M.D.3
Gonzales, J.X.4
Shames, D.S.5
Sato, M.6
Kulkarni, A.7
Wistuba, I.I.8
Girard, L.9
Minna, J.D.10
-
69
-
-
85020839679
-
Treatment advances in small cell lung cancer (SCLC)
-
28579387
-
Waqar SN, Morgensztern D. Treatment advances in small cell lung cancer (SCLC). Pharmacol Ther. 2017;180:16-23.
-
(2017)
Pharmacol Ther
, vol.180
, pp. 16-23
-
-
Waqar, S.N.1
Morgensztern, D.2
-
70
-
-
85045296183
-
Current and future therapeutic approaches for the treatment of small cell lung cancer
-
29544351
-
Rossi A, Tay R, Chiramel J, Prelaj A, Califano R. Current and future therapeutic approaches for the treatment of small cell lung cancer. Expert Rev Anticancer Ther. 2018;18(5):473-86.
-
(2018)
Expert Rev Anticancer Ther
, vol.18
, Issue.5
, pp. 473-486
-
-
Rossi, A.1
Tay, R.2
Chiramel, J.3
Prelaj, A.4
Califano, R.5
-
71
-
-
80052265739
-
Anti-tumour/metastasis effects of the potassium-sparing diuretic amiloride: An orally active anti-cancer drug waiting for its call-of-duty?
-
21544803
-
Matthews H, Ranson M, Kelso MJ. Anti-tumour/metastasis effects of the potassium-sparing diuretic amiloride: an orally active anti-cancer drug waiting for its call-of-duty? Int J Cancer. 2011;129(9):2051-61.
-
(2011)
Int J Cancer
, vol.129
, Issue.9
, pp. 2051-2061
-
-
Matthews, H.1
Ranson, M.2
Kelso, M.J.3
-
72
-
-
84976620845
-
Potential Roles of Amiloride-Sensitive Sodium Channels in Cancer Development
-
27403419 4926023
-
Xu S, Liu C, Ma Y, Ji HL, Li X. Potential Roles of Amiloride-Sensitive Sodium Channels in Cancer Development. Biomed Res Int. 2016;2016:2190216.
-
(2016)
Biomed Res Int
, vol.2016
, pp. 2190216
-
-
Xu, S.1
Liu, C.2
Ma, Y.3
Ji, H.L.4
Li, X.5
-
73
-
-
85044764269
-
The Epithelial Sodium Channel (alphaENaC) Is a Downstream Therapeutic Target of ASCL1 in Pulmonary Neuroendocrine Tumors
-
29413762 5884185
-
He M, Liu S, Gallolu Kankanamalage S, Borromeo MD, Girard L, Gazdar AF, Minna JD, Johnson JE, Cobb MH. The Epithelial Sodium Channel (alphaENaC) Is a Downstream Therapeutic Target of ASCL1 in Pulmonary Neuroendocrine Tumors. Transl Oncol. 2018;11(2):292-9.
-
(2018)
Transl Oncol
, vol.11
, Issue.2
, pp. 292-299
-
-
He, M.1
Liu, S.2
Gallolu Kankanamalage, S.3
Borromeo, M.D.4
Girard, L.5
Gazdar, A.F.6
Minna, J.D.7
Johnson, J.E.8
Cobb, M.H.9
-
74
-
-
85015149861
-
Therapeutic strategies of drug repositioning targeting autophagy to induce cancer cell death: From pathophysiology to treatment
-
28279189 5345270
-
Yoshida GJ. Therapeutic strategies of drug repositioning targeting autophagy to induce cancer cell death: from pathophysiology to treatment. J Hematol Oncol. 2017;10(1):67.
-
(2017)
J Hematol Oncol
, vol.10
, Issue.1
, pp. 67
-
-
Yoshida, G.J.1
-
75
-
-
67651153048
-
New clinical developments in histone deacetylase inhibitors for epigenetic therapy of cancer
-
19486511 2695818
-
Cang S, Ma Y, Liu D. New clinical developments in histone deacetylase inhibitors for epigenetic therapy of cancer. J Hematol Oncol. 2009;2:22.
-
(2009)
J Hematol Oncol
, vol.2
, pp. 22
-
-
Cang, S.1
Ma, Y.2
Liu, D.3
-
76
-
-
84880184328
-
Histone deacetylase inhibitor potentiated the ability of MTOR inhibitor to induce autophagic cell death in Burkitt leukemia/lymphoma
-
23866964 3722002
-
Dong LH, Cheng S, Zheng Z, Wang L, Shen Y, Shen ZX, Chen SJ, Zhao WL. Histone deacetylase inhibitor potentiated the ability of MTOR inhibitor to induce autophagic cell death in Burkitt leukemia/lymphoma. J Hematol Oncol. 2013;6:53.
-
(2013)
J Hematol Oncol
, vol.6
, pp. 53
-
-
Dong, L.H.1
Cheng, S.2
Zheng, Z.3
Wang, L.4
Shen, Y.5
Shen, Z.X.6
Chen, S.J.7
Zhao, W.L.8
-
77
-
-
0035889955
-
Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: A report from the Children's Cancer Group
-
11745206
-
Goto S, Umehara S, Gerbing RB, Stram DO, Brodeur GM, Seeger RC, Lukens JN, Matthay KK, Shimada H. Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group. Cancer. 2001;92(10):2699-708.
-
(2001)
Cancer
, vol.92
, Issue.10
, pp. 2699-2708
-
-
Goto, S.1
Umehara, S.2
Gerbing, R.B.3
Stram, D.O.4
Brodeur, G.M.5
Seeger, R.C.6
Lukens, J.N.7
Matthay, K.K.8
Shimada, H.9
-
78
-
-
78651189519
-
Tumors of Neural Crest Origin; Biochemical and Pathological Correlation
-
14318483
-
Greer M, Anton AH, Williams CM, Echevarria RA. Tumors of Neural Crest Origin; Biochemical and Pathological Correlation. Arch Neurol. 1965;13:139-48.
-
(1965)
Arch Neurol
, vol.13
, pp. 139-148
-
-
Greer, M.1
Anton, A.H.2
Williams, C.M.3
Echevarria, R.A.4
-
79
-
-
0037366067
-
Neuroblastoma: Biological insights into a clinical enigma
-
12612655
-
Brodeur GM. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer. 2003;3(3):203-16.
-
(2003)
Nat Rev Cancer
, vol.3
, Issue.3
, pp. 203-216
-
-
Brodeur, G.M.1
-
80
-
-
84975299347
-
Reactivation of p53 via MDM2 inhibition
-
26492369 4632320
-
Kim ES, Shohet JM. Reactivation of p53 via MDM2 inhibition. Cell Death Dis. 2015;6:e1936.
-
(2015)
Cell Death Dis
, vol.6
, pp. e1936
-
-
Kim, E.S.1
Shohet, J.M.2
-
81
-
-
85045528969
-
MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastoma
-
29755654 5945521
-
Agarwal S, Milazzo G, Rajapakshe K, Bernardi R, Chen Z, Barberi E, Koster J, Perini G, Coarfa C, Shohet JM. MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastoma. Oncotarget. 2018;9(29):20323-38.
-
(2018)
Oncotarget
, vol.9
, Issue.29
, pp. 20323-20338
-
-
Agarwal, S.1
Milazzo, G.2
Rajapakshe, K.3
Bernardi, R.4
Chen, Z.5
Barberi, E.6
Koster, J.7
Perini, G.8
Coarfa, C.9
Shohet, J.M.10
-
82
-
-
80053630941
-
Oct-4+/Tenascin C+ neuroblastoma cells serve as progenitors of tumor-derived endothelial cells
-
21403679 3193450
-
Pezzolo A, Parodi F, Marimpietri D, Raffaghello L, Cocco C, Pistorio A, Mosconi M, Gambini C, Cilli M, Deaglio S, et al. Oct-4+/Tenascin C+ neuroblastoma cells serve as progenitors of tumor-derived endothelial cells. Cell Res. 2011;21(10):1470-86.
-
(2011)
Cell Res
, vol.21
, Issue.10
, pp. 1470-1486
-
-
Pezzolo, A.1
Parodi, F.2
Marimpietri, D.3
Raffaghello, L.4
Cocco, C.5
Pistorio, A.6
Mosconi, M.7
Gambini, C.8
Cilli, M.9
Deaglio, S.10
-
83
-
-
84868210731
-
LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression
-
Molenaar JJ, Domingo-Fernandez R, Ebus ME, Lindner S, Koster J, Drabek K, Mestdagh P, van Sluis P, Valentijn LJ, van Nes J, et al. LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression. Nat Genet. 2012;44(11):1199-1206.
-
(2012)
Nat Genet
, vol.44
, Issue.11
, pp. 1199-1206
-
-
Molenaar, J.J.1
Domingo-Fernandez, R.2
Ebus, M.E.3
Lindner, S.4
Koster, J.5
Drabek, K.6
Mestdagh, P.7
Van Sluis, P.8
Valentijn, L.J.9
Van Nes, J.10
-
84
-
-
0028926896
-
Human neuroblastoma I-type cells are malignant neural crest stem cells
-
7794812
-
Ross RA, Spengler BA, Domenech C, Porubcin M, Rettig WJ, Biedler JL. Human neuroblastoma I-type cells are malignant neural crest stem cells. Cell Growth Differ. 1995;6(4):449-56.
-
(1995)
Cell Growth Differ
, vol.6
, Issue.4
, pp. 449-456
-
-
Ross, R.A.1
Spengler, B.A.2
Domenech, C.3
Porubcin, M.4
Rettig, W.J.5
Biedler, J.L.6
-
85
-
-
84885052613
-
Targeting neuroblastoma stem cells with retinoic acid and proteasome inhibitor
-
e76761 24116151 3792090
-
Hammerle B, Yanez Y, Palanca S, Canete A, Burks DJ, Castel V, Font de Mora J. Targeting neuroblastoma stem cells with retinoic acid and proteasome inhibitor. PLoS One. 2013;8(10):e76761.
-
(2013)
PLoS One
, vol.8
, Issue.10
-
-
Hammerle, B.1
Yanez, Y.2
Palanca, S.3
Canete, A.4
Burks, D.J.5
Castel, V.6
Font De Mora, J.7
-
86
-
-
84936985363
-
Functional interplay between MYCN, NCYM, and OCT4 promotes aggressiveness of human neuroblastomas
-
25880909 4520635
-
Kaneko Y, Suenaga Y, Islam SM, Matsumoto D, Nakamura Y, Ohira M, Yokoi S, Nakagawara A. Functional interplay between MYCN, NCYM, and OCT4 promotes aggressiveness of human neuroblastomas. Cancer Sci. 2015;106(7):840-7.
-
(2015)
Cancer Sci
, vol.106
, Issue.7
, pp. 840-847
-
-
Kaneko, Y.1
Suenaga, Y.2
Islam, S.M.3
Matsumoto, D.4
Nakamura, Y.5
Ohira, M.6
Yokoi, S.7
Nakagawara, A.8
-
87
-
-
55649123695
-
Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas
-
Westermann F, Muth D, Benner A, Bauer T, Henrich KO, Oberthuer A, Brors B, Beissbarth T, Vandesompele J, Pattyn F, et al. Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas. Genome Biol. 2008;9(10):R150.
-
(2008)
Genome Biol.
, vol.9
, Issue.10
, pp. R150
-
-
Westermann, F.1
Muth, D.2
Benner, A.3
Bauer, T.4
Henrich, K.O.5
Oberthuer, A.6
Brors, B.7
Beissbarth, T.8
Vandesompele, J.9
Pattyn, F.10
-
88
-
-
84883488965
-
Kruppel-like factor 4 (KLF4) suppresses neuroblastoma cell growth and determines non-tumorigenic lineage differentiation
-
23045286
-
Shum CK, Lau ST, Tsoi LL, Chan LK, Yam JW, Ohira M, Nakagawara A, Tam PK, Ngan ES. Kruppel-like factor 4 (KLF4) suppresses neuroblastoma cell growth and determines non-tumorigenic lineage differentiation. Oncogene. 2013;32(35):4086-99.
-
(2013)
Oncogene
, vol.32
, Issue.35
, pp. 4086-4099
-
-
Shum, C.K.1
Lau, S.T.2
Tsoi, L.L.3
Chan, L.K.4
Yam, J.W.5
Ohira, M.6
Nakagawara, A.7
Tam, P.K.8
Ngan, E.S.9
-
89
-
-
0025288707
-
N-myc mRNA forms an RNA-RNA duplex with endogenous antisense transcripts
-
1695323 360949
-
Krystal GW, Armstrong BC, Battey JF. N-myc mRNA forms an RNA-RNA duplex with endogenous antisense transcripts. Mol Cell Biol. 1990;10(8):4180-91.
-
(1990)
Mol Cell Biol
, vol.10
, Issue.8
, pp. 4180-4191
-
-
Krystal, G.W.1
Armstrong, B.C.2
Battey, J.F.3
-
90
-
-
0026881782
-
Isolation and characterization of complementary DNA for N-cym, a gene encoded by the DNA strand opposite to N-myc
-
1419902
-
Armstrong BC, Krystal GW. Isolation and characterization of complementary DNA for N-cym, a gene encoded by the DNA strand opposite to N-myc. Cell Growth Differ. 1992;3(6):385-90.
-
(1992)
Cell Growth Differ
, vol.3
, Issue.6
, pp. 385-390
-
-
Armstrong, B.C.1
Krystal, G.W.2
-
91
-
-
84896730858
-
NCYM, a Cis-antisense gene of MYCN, encodes a de novo evolved protein that inhibits GSK3beta resulting in the stabilization of MYCN in human neuroblastomas
-
Suenaga Y, Islam SM, Alagu J, Kaneko Y, Kato M, Tanaka Y, Kawana H, Hossain S, Matsumoto D, Yamamoto M, et al. NCYM, a Cis-antisense gene of MYCN, encodes a de novo evolved protein that inhibits GSK3beta resulting in the stabilization of MYCN in human neuroblastomas. PLoS Genet. 2014;10(1):e1003996.
-
(2014)
PLoS Genet
, vol.10
, Issue.1
, pp. e1003996
-
-
Suenaga, Y.1
Islam, S.M.2
Alagu, J.3
Kaneko, Y.4
Kato, M.5
Tanaka, Y.6
Kawana, H.7
Hossain, S.8
Matsumoto, D.9
Yamamoto, M.10
-
92
-
-
0033554684
-
Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group
-
Matthay KK, Villablanca JG, Seeger RC, Stram DO, Harris RE, Ramsay NK, Swift P, Shimada H, Black CT, Brodeur GM, et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med. 1999;341(16):1165-1173.
-
(1999)
N Engl J Med.
, vol.341
, Issue.16
, pp. 1165-1173
-
-
Matthay, K.K.1
Villablanca, J.G.2
Seeger, R.C.3
Stram, D.O.4
Harris, R.E.5
Ramsay, N.K.6
Swift, P.7
Shimada, H.8
Black, C.T.9
Brodeur, G.M.10
-
93
-
-
0037767742
-
Retinoid therapy of high-risk neuroblastoma
-
12880980
-
Reynolds CP, Matthay KK, Villablanca JG, Maurer BJ. Retinoid therapy of high-risk neuroblastoma. Cancer Lett. 2003;197(1-2):185-92.
-
(2003)
Cancer Lett
, vol.197
, Issue.1-2
, pp. 185-192
-
-
Reynolds, C.P.1
Matthay, K.K.2
Villablanca, J.G.3
Maurer, B.J.4
-
94
-
-
0035969112
-
All trans retinoic acid in acute promyelocytic leukemia
-
11704842
-
Degos L, Wang ZY. All trans retinoic acid in acute promyelocytic leukemia. Oncogene. 2001;20(49):7140-5.
-
(2001)
Oncogene
, vol.20
, Issue.49
, pp. 7140-7145
-
-
Degos, L.1
Wang, Z.Y.2
-
95
-
-
0037974596
-
Treatment of acute promyelocytic leukemia with ATRA and As2O3: A model of molecular target-based cancer therapy
-
12642682
-
Fang J, Chen SJ, Tong JH, Wang ZG, Chen GQ, Chen Z. Treatment of acute promyelocytic leukemia with ATRA and As2O3: a model of molecular target-based cancer therapy. Cancer Biol Ther. 2002;1(6):614-20.
-
(2002)
Cancer Biol Ther
, vol.1
, Issue.6
, pp. 614-620
-
-
Fang, J.1
Chen, S.J.2
Tong, J.H.3
Wang, Z.G.4
Chen, G.Q.5
Chen, Z.6
-
96
-
-
34247614521
-
HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity
-
17482131
-
Zhang H, Gao P, Fukuda R, Kumar G, Krishnamachary B, Zeller KI, Dang CV, Semenza GL. HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity. Cancer Cell. 2007;11(5):407-20.
-
(2007)
Cancer Cell
, vol.11
, Issue.5
, pp. 407-420
-
-
Zhang, H.1
Gao, P.2
Fukuda, R.3
Kumar, G.4
Krishnamachary, B.5
Zeller, K.I.6
Dang, C.V.7
Semenza, G.L.8
-
97
-
-
70350728803
-
MYC-induced cancer cell energy metabolism and therapeutic opportunities
-
19861459 2783410
-
Dang CV, Le A, Gao P. MYC-induced cancer cell energy metabolism and therapeutic opportunities. Clin Cancer Res. 2009;15(21):6479-83.
-
(2009)
Clin Cancer Res
, vol.15
, Issue.21
, pp. 6479-6483
-
-
Dang, C.V.1
Le, A.2
Gao, P.3
-
98
-
-
84861891911
-
Reprogramming of proline and glutamine metabolism contributes to the proliferative and metabolic responses regulated by oncogenic transcription factor c-MYC
-
22615405 3384197
-
Liu W, Le A, Hancock C, Lane AN, Dang CV, Fan TW, Phang JM. Reprogramming of proline and glutamine metabolism contributes to the proliferative and metabolic responses regulated by oncogenic transcription factor c-MYC. Proc Natl Acad Sci U S A. 2012;109(23):8983-8.
-
(2012)
Proc Natl Acad Sci U S A
, vol.109
, Issue.23
, pp. 8983-8988
-
-
Liu, W.1
Le, A.2
Hancock, C.3
Lane, A.N.4
Dang, C.V.5
Fan, T.W.6
Phang, J.M.7
-
99
-
-
84887430714
-
MTOR complex 2 controls glycolytic metabolism in glioblastoma through FoxO acetylation and upregulation of c-Myc
-
24140020
-
Masui K, Tanaka K, Akhavan D, Babic I, Gini B, Matsutani T, Iwanami A, Liu F, Villa GR, Gu Y, et al. mTOR complex 2 controls glycolytic metabolism in glioblastoma through FoxO acetylation and upregulation of c-Myc. Cell Metab. 2013;18(5):726-39.
-
(2013)
Cell Metab
, vol.18
, Issue.5
, pp. 726-739
-
-
Masui, K.1
Tanaka, K.2
Akhavan, D.3
Babic, I.4
Gini, B.5
Matsutani, T.6
Iwanami, A.7
Liu, F.8
Villa, G.R.9
Gu, Y.10
-
100
-
-
84885378901
-
Glutamine sensitivity analysis identifies the xCT antiporter as a common triple-negative breast tumor therapeutic target
-
24094812 3931310
-
Timmerman LA, Holton T, Yuneva M, Louie RJ, Padro M, Daemen A, Hu M, Chan DA, Ethier SP, van 't Veer LJ, et al. Glutamine sensitivity analysis identifies the xCT antiporter as a common triple-negative breast tumor therapeutic target. Cancer Cell. 2013;24(4):450-65.
-
(2013)
Cancer Cell
, vol.24
, Issue.4
, pp. 450-465
-
-
Timmerman, L.A.1
Holton, T.2
Yuneva, M.3
Louie, R.J.4
Padro, M.5
Daemen, A.6
Hu, M.7
Chan, D.A.8
Ethier, S.P.9
Van 'T Veer, L.J.10
-
101
-
-
84943246936
-
Metabolic reprogramming: The emerging concept and associated therapeutic strategies
-
26445347 4595070
-
Yoshida GJ. Metabolic reprogramming: the emerging concept and associated therapeutic strategies. J Exp Clin Cancer Res. 2015;34:111.
-
(2015)
J Exp Clin Cancer Res
, vol.34
, pp. 111
-
-
Yoshida, G.J.1
-
102
-
-
0030921103
-
C-Myc transactivation of LDH-A: Implications for tumor metabolism and growth
-
9192621 21214
-
Shim H, Dolde C, Lewis BC, Wu CS, Dang G, Jungmann RA, Dalla-Favera R, Dang CV. c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. Proc Natl Acad Sci U S A. 1997;94(13):6658-63.
-
(1997)
Proc Natl Acad Sci U S A
, vol.94
, Issue.13
, pp. 6658-6663
-
-
Shim, H.1
Dolde, C.2
Lewis, B.C.3
Wu, C.S.4
Dang, G.5
Jungmann, R.A.6
Dalla-Favera, R.7
Dang, C.V.8
-
103
-
-
0034327416
-
Tumor induction by the c-Myc target genes rcl and lactate dehydrogenase A
-
11085542
-
Lewis BC, Prescott JE, Campbell SE, Shim H, Orlowski RZ, Dang CV. Tumor induction by the c-Myc target genes rcl and lactate dehydrogenase A. Cancer Res. 2000;60(21):6178-83.
-
(2000)
Cancer Res
, vol.60
, Issue.21
, pp. 6178-6183
-
-
Lewis, B.C.1
Prescott, J.E.2
Campbell, S.E.3
Shim, H.4
Orlowski, R.Z.5
Dang, C.V.6
-
104
-
-
84930221860
-
The c-Myc-LDHA axis positively regulates aerobic glycolysis and promotes tumor progression in pancreatic cancer
-
26021472 4452209
-
He TL, Zhang YJ, Jiang H, Li XH, Zhu H, Zheng KL. The c-Myc-LDHA axis positively regulates aerobic glycolysis and promotes tumor progression in pancreatic cancer. Med Oncol. 2015;32(7):187.
-
(2015)
Med Oncol
, vol.32
, Issue.7
, pp. 187
-
-
He, T.L.1
Zhang, Y.J.2
Jiang, H.3
Li, X.H.4
Zhu, H.5
Zheng, K.L.6
-
105
-
-
21744442902
-
Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis
-
15988031 1168798
-
Li F, Wang Y, Zeller KI, Potter JJ, Wonsey DR, O'Donnell KA, Kim JW, Yustein JT, Lee LA, Dang CV. Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis. Mol Cell Biol. 2005;25(14):6225-34.
-
(2005)
Mol Cell Biol
, vol.25
, Issue.14
, pp. 6225-6234
-
-
Li, F.1
Wang, Y.2
Zeller, K.I.3
Potter, J.J.4
Wonsey, D.R.5
O'Donnell, K.A.6
Kim, J.W.7
Yustein, J.T.8
Lee, L.A.9
Dang, C.V.10
-
107
-
-
43549098260
-
The oncogene c-Myc coordinates regulation of metabolic networks to enable rapid cell cycle entry
-
18414044 2518168
-
Morrish F, Neretti N, Sedivy JM, Hockenbery DM. The oncogene c-Myc coordinates regulation of metabolic networks to enable rapid cell cycle entry. Cell Cycle. 2008;7(8):1054-66.
-
(2008)
Cell Cycle
, vol.7
, Issue.8
, pp. 1054-1066
-
-
Morrish, F.1
Neretti, N.2
Sedivy, J.M.3
Hockenbery, D.M.4
-
108
-
-
84962028922
-
Dysregulated metabolism contributes to oncogenesis
-
Hirschey MD, DeBerardinis RJ, Diehl AME, Drew JE, Frezza C, Green MF, Jones LW, Ko YH, Le A, Lea MA, et al. Dysregulated metabolism contributes to oncogenesis. Semin Cancer Biol. 2015;35 Suppl:S129-S150.
-
(2015)
Semin Cancer Biol.
, vol.35
, pp. S129-S150
-
-
Hirschey, M.D.1
Deberardinis, R.J.2
Ame, D.3
Drew, J.E.4
Frezza, C.5
Green, M.F.6
Jones, L.W.7
Ko, Y.H.8
Le, A.9
Ma, L.10
-
109
-
-
57749088701
-
Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction
-
Wise DR, DeBerardinis RJ, Mancuso A, Sayed N, Zhang XY, Pfeiffer HK, Nissim I, Daikhin E, Yudkoff M, McMahon SB, et al. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc Natl Acad Sci U S A. 2008;105(48):18782-18787.
-
(2008)
Proc Natl Acad Sci U S A
, vol.105
, Issue.48
, pp. 18782-18787
-
-
Wise, D.R.1
Deberardinis, R.J.2
Mancuso, A.3
Sayed, N.4
Zhang, X.Y.5
Pfeiffer, H.K.6
Nissim, I.7
Daikhin, E.8
Yudkoff, M.9
McMahon, S.B.10
-
110
-
-
37549008310
-
Widespread microRNA repression by Myc contributes to tumorigenesis
-
18066065
-
Chang TC, Yu D, Lee YS, Wentzel EA, Arking DE, West KM, Dang CV, Thomas-Tikhonenko A, Mendell JT. Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet. 2008;40(1):43-50.
-
(2008)
Nat Genet
, vol.40
, Issue.1
, pp. 43-50
-
-
Chang, T.C.1
Yu, D.2
Lee, Y.S.3
Wentzel, E.A.4
Arking, D.E.5
West, K.M.6
Dang, C.V.7
Thomas-Tikhonenko, A.8
Mendell, J.T.9
-
111
-
-
64749116346
-
C-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism
-
Gao P, Tchernyshyov I, Chang TC, Lee YS, Kita K, Ochi T, Zeller KI, De Marzo AM, Van Eyk JE, Mendell JT, et al. c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature. 2009;458(7239):762-765.
-
(2009)
Nature
, vol.458
, Issue.7239
, pp. 762-765
-
-
Gao, P.1
Tchernyshyov, I.2
Chang, T.C.3
Lee, Y.S.4
Kita, K.5
Ochi, T.6
Zeller, K.I.7
De Marzo, A.M.8
Van Eyk, J.E.9
Mendell, J.T.10
-
112
-
-
77954945639
-
MiR-17-92 cluster: Ups and downs in cancer and aging
-
20437201 2899009
-
Grillari J, Hackl M, Grillari-Voglauer R. miR-17-92 cluster: ups and downs in cancer and aging. Biogerontology. 2010;11(4):501-6.
-
(2010)
Biogerontology
, vol.11
, Issue.4
, pp. 501-506
-
-
Grillari, J.1
Hackl, M.2
Grillari-Voglauer, R.3
-
113
-
-
84899755840
-
MiR-17-92 cluster targets phosphatase and tensin homology and Ikaros Family Zinc Finger 4 to promote TH17-mediated inflammation
-
24644282 4007439
-
Liu SQ, Jiang S, Li C, Zhang B, Li QJ. miR-17-92 cluster targets phosphatase and tensin homology and Ikaros Family Zinc Finger 4 to promote TH17-mediated inflammation. J Biol Chem. 2014;289(18):12446-56.
-
(2014)
J Biol Chem
, vol.289
, Issue.18
, pp. 12446-12456
-
-
Liu, S.Q.1
Jiang, S.2
Li, C.3
Zhang, B.4
Li, Q.J.5
-
114
-
-
84992520625
-
A c-Myc/miR17-92/Pten Axis Controls PI3K-Mediated Positive and Negative Selection in B Cell Development and Reconstitutes CD19 Deficiency
-
27346348
-
Benhamou D, Labi V, Novak R, Dai I, Shafir-Alon S, Weiss A, Gaujoux R, Arnold R, Shen-Orr SS, Rajewsky K, et al. A c-Myc/miR17-92/Pten Axis Controls PI3K-Mediated Positive and Negative Selection in B Cell Development and Reconstitutes CD19 Deficiency. Cell Rep. 2016;16(2):419-31.
-
(2016)
Cell Rep
, vol.16
, Issue.2
, pp. 419-431
-
-
Benhamou, D.1
Labi, V.2
Novak, R.3
Dai, I.4
Shafir-Alon, S.5
Weiss, A.6
Gaujoux, R.7
Arnold, R.8
Shen-Orr, S.S.9
Rajewsky, K.10
-
115
-
-
34347402459
-
Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells
-
17606868 2064426
-
Yuneva M, Zamboni N, Oefner P, Sachidanandam R, Lazebnik Y. Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells. J Cell Biol. 2007;178(1):93-105.
-
(2007)
J Cell Biol
, vol.178
, Issue.1
, pp. 93-105
-
-
Yuneva, M.1
Zamboni, N.2
Oefner, P.3
Sachidanandam, R.4
Lazebnik, Y.5
-
116
-
-
84964312498
-
Metabolic characterization of triple negative breast cancer
-
25495193 4295321
-
Cao MD, Lamichhane S, Lundgren S, Bofin A, Fjosne H, Giskeodegard GF, Bathen TF. Metabolic characterization of triple negative breast cancer. BMC Cancer. 2014;14:941.
-
(2014)
BMC Cancer
, vol.14
, pp. 941
-
-
Cao, M.D.1
Lamichhane, S.2
Lundgren, S.3
Bofin, A.4
Fjosne, H.5
Giskeodegard, G.F.6
Bathen, T.F.7
-
117
-
-
79952528125
-
CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth
-
21397861
-
Ishimoto T, Nagano O, Yae T, Tamada M, Motohara T, Oshima H, Oshima M, Ikeda T, Asaba R, Yagi H, et al. CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth. Cancer Cell. 2011;19(3):387-400.
-
(2011)
Cancer Cell
, vol.19
, Issue.3
, pp. 387-400
-
-
Ishimoto, T.1
Nagano, O.2
Yae, T.3
Tamada, M.4
Motohara, T.5
Oshima, H.6
Oshima, M.7
Ikeda, T.8
Asaba, R.9
Yagi, H.10
-
118
-
-
84892432945
-
Inversed relationship between CD44 variant and c-Myc due to oxidative stress-induced canonical Wnt activation
-
24333422
-
Yoshida GJ, Saya H. Inversed relationship between CD44 variant and c-Myc due to oxidative stress-induced canonical Wnt activation. Biochem Biophys Res Commun. 2014;443(2):622-7.
-
(2014)
Biochem Biophys Res Commun
, vol.443
, Issue.2
, pp. 622-627
-
-
Yoshida, G.J.1
Saya, H.2
-
119
-
-
84956579802
-
Therapeutic strategies targeting cancer stem cells
-
26362755
-
Yoshida GJ, Saya H. Therapeutic strategies targeting cancer stem cells. Cancer Sci. 2016;107(1):5-11.
-
(2016)
Cancer Sci
, vol.107
, Issue.1
, pp. 5-11
-
-
Yoshida, G.J.1
Saya, H.2
-
120
-
-
85012951878
-
The heterogeneity of cancer stem-like cells at the invasive front
-
28289330 5307924
-
Yoshida GJ. The heterogeneity of cancer stem-like cells at the invasive front. Cancer Cell Int. 2017;17:23.
-
(2017)
Cancer Cell Int
, vol.17
, pp. 23
-
-
Yoshida, G.J.1
-
121
-
-
34249803325
-
The transport of glutamine into mammalian cells
-
17127344
-
McGivan JD, Bungard CI. The transport of glutamine into mammalian cells. Front Biosci. 2007;12:874-82.
-
(2007)
Front Biosci
, vol.12
, pp. 874-882
-
-
McGivan, J.D.1
Bungard, C.I.2
-
122
-
-
85038036739
-
Glutamine Transport and Mitochondrial Metabolism in Cancer Cell Growth
-
29376023 5770653
-
Scalise M, Pochini L, Galluccio M, Console L, Indiveri C. Glutamine Transport and Mitochondrial Metabolism in Cancer Cell Growth. Front Oncol. 2017;7:306.
-
(2017)
Front Oncol
, vol.7
, pp. 306
-
-
Scalise, M.1
Pochini, L.2
Galluccio, M.3
Console, L.4
Indiveri, C.5
-
123
-
-
84954410074
-
Metabolic reprogramming in cancer cells: Glycolysis, glutaminolysis, and Bcl-2 proteins as novel therapeutic targets for cancer
-
26791262 4721116
-
Li C, Zhang G, Zhao L, Ma Z, Chen H. Metabolic reprogramming in cancer cells: glycolysis, glutaminolysis, and Bcl-2 proteins as novel therapeutic targets for cancer. World J Surg Oncol. 2016;14(1):15.
-
(2016)
World J Surg Oncol
, vol.14
, Issue.1
, pp. 15
-
-
Li, C.1
Zhang, G.2
Zhao, L.3
Ma, Z.4
Chen, H.5
-
124
-
-
0034647570
-
G6PD deficient cells and the bioreduction of disulfides: Effects of DHEA, GSH depletion and phenylarsine oxide
-
10891335
-
Biaglow JE, Ayene IS, Koch CJ, Donahue J, Stamato TD, Tuttle SW. G6PD deficient cells and the bioreduction of disulfides: effects of DHEA, GSH depletion and phenylarsine oxide. Biochem Biophys Res Commun. 2000;273(3):846-52.
-
(2000)
Biochem Biophys Res Commun
, vol.273
, Issue.3
, pp. 846-852
-
-
Biaglow, J.E.1
Ayene, I.S.2
Koch, C.J.3
Donahue, J.4
Stamato, T.D.5
Tuttle, S.W.6
-
125
-
-
84862278857
-
The Role of Mitochondrial NADPH-Dependent Isocitrate Dehydrogenase in Cancer Cells
-
273947 22675360 3363418
-
Smolkova K, Jezek P. The Role of Mitochondrial NADPH-Dependent Isocitrate Dehydrogenase in Cancer Cells. Int J Cell Biol. 2012;2012:273947.
-
(2012)
Int J Cell Biol
, vol.2012
-
-
Smolkova, K.1
Jezek, P.2
-
126
-
-
12444279265
-
On the origin of cancer cells
-
13298683
-
Warburg O. On the origin of cancer cells. Science. 1956;123(3191):309-14.
-
(1956)
Science
, vol.123
, Issue.3191
, pp. 309-314
-
-
Warburg, O.1
-
127
-
-
85006768050
-
The Metabolism of Tumors in the Body
-
19872213 2140820
-
Warburg O, Wind F, Negelein E. The Metabolism of Tumors in the Body. J Gen Physiol. 1927;8(6):519-30.
-
(1927)
J Gen Physiol
, vol.8
, Issue.6
, pp. 519-530
-
-
Warburg, O.1
Wind, F.2
Negelein, E.3
-
128
-
-
26444469502
-
Detection of resistance to imatinib by metabolic profiling: Clinical and drug development implications
-
16196499
-
Serkova N, Boros LG. Detection of resistance to imatinib by metabolic profiling: clinical and drug development implications. Am J Pharmacogenomics. 2005;5(5):293-302.
-
(2005)
Am J Pharmacogenomics
, vol.5
, Issue.5
, pp. 293-302
-
-
Serkova, N.1
Boros, L.G.2
-
129
-
-
79952227361
-
CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression
-
21393860 3049398
-
Brown RL, Reinke LM, Damerow MS, Perez D, Chodosh LA, Yang J, Cheng C. CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression. J Clin Invest. 2011;121(3):1064-74.
-
(2011)
J Clin Invest
, vol.121
, Issue.3
, pp. 1064-1074
-
-
Brown, R.L.1
Reinke, L.M.2
Damerow, M.S.3
Perez, D.4
Chodosh, L.A.5
Yang, J.6
Cheng, C.7
-
130
-
-
84863321158
-
Alternative splicing of CD44 mRNA by ESRP1 enhances lung colonization of metastatic cancer cell
-
Yae T, Tsuchihashi K, Ishimoto T, Motohara T, Yoshikawa M, Yoshida GJ, Wada T, Masuko T, Mogushi K, Tanaka H, et al. Alternative splicing of CD44 mRNA by ESRP1 enhances lung colonization of metastatic cancer cell. Nat Commun. 2012;3:883.
-
(2012)
Nat Commun.
, vol.3
, pp. 883
-
-
Yae, T.1
Tsuchihashi, K.2
Ishimoto, T.3
Motohara, T.4
Yoshikawa, M.5
Yoshida, G.J.6
Wada, T.7
Masuko, T.8
Mogushi, K.9
Tanaka, H.10
-
131
-
-
0242404063
-
Identification and characterisation of human xCT that co-expresses, with 4F2 heavy chain, the amino acid transport activity system xc
-
11417227
-
Bassi MT, Gasol E, Manzoni M, Pineda M, Riboni M, Martin R, Zorzano A, Borsani G, Palacin M. Identification and characterisation of human xCT that co-expresses, with 4F2 heavy chain, the amino acid transport activity system xc. Pflugers Arch. 2001;442(2):286-96.
-
(2001)
Pflugers Arch
, vol.442
, Issue.2
, pp. 286-296
-
-
Bassi, M.T.1
Gasol, E.2
Manzoni, M.3
Pineda, M.4
Riboni, M.5
Martin, R.6
Zorzano, A.7
Borsani, G.8
Palacin, M.9
-
132
-
-
77949593175
-
CD44+ slow-cycling tumor cell expansion is triggered by cooperative actions of Wnt and prostaglandin E2 in gastric tumorigenesis
-
20028388
-
Ishimoto T, Oshima H, Oshima M, Kai K, Torii R, Masuko T, Baba H, Saya H, Nagano O. CD44+ slow-cycling tumor cell expansion is triggered by cooperative actions of Wnt and prostaglandin E2 in gastric tumorigenesis. Cancer Sci. 2010;101(3):673-8.
-
(2010)
Cancer Sci
, vol.101
, Issue.3
, pp. 673-678
-
-
Ishimoto, T.1
Oshima, H.2
Oshima, M.3
Kai, K.4
Torii, R.5
Masuko, T.6
Baba, H.7
Saya, H.8
Nagano, O.9
-
133
-
-
80052566377
-
Tumor entrained neutrophils inhibit seeding in the premetastatic lung
-
21907922 3172582
-
Granot Z, Henke E, Comen EA, King TA, Norton L, Benezra R. Tumor entrained neutrophils inhibit seeding in the premetastatic lung. Cancer Cell. 2011;20(3):300-14.
-
(2011)
Cancer Cell
, vol.20
, Issue.3
, pp. 300-314
-
-
Granot, Z.1
Henke, E.2
Comen, E.A.3
King, T.A.4
Norton, L.5
Benezra, R.6
-
134
-
-
84861541814
-
Ferroptosis: An iron-dependent form of nonapoptotic cell death
-
Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060-1072.
-
(2012)
Cell
, vol.149
, Issue.5
, pp. 1060-1072
-
-
Dixon, S.J.1
Lemberg, K.M.2
Lamprecht, M.R.3
Skouta, R.4
Zaitsev, E.M.5
Gleason, C.E.6
Patel, D.N.7
Bauer, A.J.8
Cantley, A.M.9
Yang, W.S.10
-
135
-
-
84901323900
-
Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis
-
Dixon SJ, Patel DN, Welsch M, Skouta R, Lee ED, Hayano M, Thomas AG, Gleason CE, Tatonetti NP, Slusher BS, et al. Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis. Elife. 2014;3:e02523.
-
(2014)
Elife
, vol.3
, pp. e02523
-
-
Dixon, S.J.1
Patel, D.N.2
Welsch, M.3
Skouta, R.4
Lee, E.D.5
Hayano, M.6
Thomas, A.G.7
Gleason, C.E.8
Tatonetti, N.P.9
Slusher, B.S.10
-
136
-
-
84962637563
-
Mechanisms of ferroptosis
-
27048822 4887533
-
Cao JY, Dixon SJ. Mechanisms of ferroptosis. Cell Mol Life Sci. 2016;73(11-12):2195-209.
-
(2016)
Cell Mol Life Sci
, vol.73
, Issue.11-12
, pp. 2195-2209
-
-
Cao, J.Y.1
Dixon, S.J.2
-
137
-
-
84892685001
-
Regulation of ferroptotic cancer cell death by GPX4
-
Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS, Cheah JH, Clemons PA, Shamji AF, Clish CB, et al. Regulation of ferroptotic cancer cell death by GPX4. Cell. 2014;156(1-2):317-331.
-
(2014)
Cell
, vol.156
, Issue.1-2
, pp. 317-331
-
-
Yang, W.S.1
Sriramaratnam, R.2
Welsch, M.E.3
Shimada, K.4
Skouta, R.5
Viswanathan, V.S.6
Cheah, J.H.7
Clemons, P.A.8
Shamji, A.F.9
Clish, C.B.10
-
138
-
-
85018380560
-
ATF4 promotes angiogenesis and neuronal cell death and confers ferroptosis in a xCT-dependent manner
-
28553953 5633655
-
Chen D, Fan Z, Rauh M, Buchfelder M, Eyupoglu IY, Savaskan N. ATF4 promotes angiogenesis and neuronal cell death and confers ferroptosis in a xCT-dependent manner. Oncogene. 2017;36(40):5593-608.
-
(2017)
Oncogene
, vol.36
, Issue.40
, pp. 5593-5608
-
-
Chen, D.1
Fan, Z.2
Rauh, M.3
Buchfelder, M.4
Eyupoglu, I.Y.5
Savaskan, N.6
-
139
-
-
85041647871
-
P53 Suppresses Metabolic Stress-Induced Ferroptosis in Cancer Cells
-
29346757 5791910
-
Tarangelo A, Magtanong L, Bieging-Rolett KT, Li Y, Ye J, Attardi LD, Dixon SJ. p53 Suppresses Metabolic Stress-Induced Ferroptosis in Cancer Cells. Cell Rep. 2018;22(3):569-75.
-
(2018)
Cell Rep
, vol.22
, Issue.3
, pp. 569-575
-
-
Tarangelo, A.1
Magtanong, L.2
Bieging-Rolett, K.T.3
Li, Y.4
Ye, J.5
Attardi, L.D.6
Dixon, S.J.7
-
140
-
-
0020958437
-
Structural and kinetic differences between the M2 type pyruvate kinases from lung and various tumors
-
6326772
-
Eigenbrodt E, Leib S, Kramer W, Friis RR, Schoner W. Structural and kinetic differences between the M2 type pyruvate kinases from lung and various tumors. Biomed Biochim Acta. 1983;42(11-12):S278-82.
-
(1983)
Biomed Biochim Acta
, vol.42
, Issue.11-12
, pp. S278-S282
-
-
Eigenbrodt, E.1
Leib, S.2
Kramer, W.3
Friis, R.R.4
Schoner, W.5
-
141
-
-
40749099894
-
Pyruvate kinase M2 is a phosphotyrosine-binding protein
-
18337815
-
Christofk HR, Vander Heiden MG, Wu N, Asara JM, Cantley LC. Pyruvate kinase M2 is a phosphotyrosine-binding protein. Nature. 2008;452(7184):181-6.
-
(2008)
Nature
, vol.452
, Issue.7184
, pp. 181-186
-
-
Christofk, H.R.1
Vander Heiden, M.G.2
Wu, N.3
Asara, J.M.4
Cantley, L.C.5
-
142
-
-
85042821230
-
PKM1 Confers Metabolic Advantages and Promotes Cell-Autonomous Tumor Cell Growth
-
29533781 e357
-
Morita M, Sato T, Nomura M, Sakamoto Y, Inoue Y, Tanaka R, Ito S, Kurosawa K, Yamaguchi K, Sugiura Y, et al. PKM1 Confers Metabolic Advantages and Promotes Cell-Autonomous Tumor Cell Growth. Cancer Cell. 2018;33(3):355-67. e357
-
(2018)
Cancer Cell
, vol.33
, Issue.3
, pp. 355-367
-
-
Morita, M.1
Sato, T.2
Nomura, M.3
Sakamoto, Y.4
Inoue, Y.5
Tanaka, R.6
Ito, S.7
Kurosawa, K.8
Yamaguchi, K.9
Sugiura, Y.10
-
145
-
-
23044500915
-
Pyruvate kinase type M2 and its role in tumor growth and spreading
-
15908230
-
Mazurek S, Boschek CB, Hugo F, Eigenbrodt E. Pyruvate kinase type M2 and its role in tumor growth and spreading. Semin Cancer Biol. 2005;15(4):300-8.
-
(2005)
Semin Cancer Biol
, vol.15
, Issue.4
, pp. 300-308
-
-
Mazurek, S.1
Boschek, C.B.2
Hugo, F.3
Eigenbrodt, E.4
-
146
-
-
40749163248
-
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
-
18337823
-
Christofk HR, Vander Heiden MG, Harris MH, Ramanathan A, Gerszten RE, Wei R, Fleming MD, Schreiber SL, Cantley LC. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature. 2008;452(7184):230-3.
-
(2008)
Nature
, vol.452
, Issue.7184
, pp. 230-233
-
-
Christofk, H.R.1
Vander Heiden, M.G.2
Harris, M.H.3
Ramanathan, A.4
Gerszten, R.E.5
Wei, R.6
Fleming, M.D.7
Schreiber, S.L.8
Cantley, L.C.9
-
147
-
-
84867559423
-
Pyruvate kinase M2: Multiple faces for conferring benefits on cancer cells
-
23071357
-
Tamada M, Suematsu M, Saya H. Pyruvate kinase M2: multiple faces for conferring benefits on cancer cells. Clin Cancer Res. 2012;18(20):5554-61.
-
(2012)
Clin Cancer Res
, vol.18
, Issue.20
, pp. 5554-5561
-
-
Tamada, M.1
Suematsu, M.2
Saya, H.3
-
148
-
-
84870598190
-
ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect
-
23178880 3511602
-
Yang W, Zheng Y, Xia Y, Ji H, Chen X, Guo F, Lyssiotis CA, Aldape K, Cantley LC, Lu Z. ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect. Nat Cell Biol. 2012;14(12):1295-304.
-
(2012)
Nat Cell Biol
, vol.14
, Issue.12
, pp. 1295-1304
-
-
Yang, W.1
Zheng, Y.2
Xia, Y.3
Ji, H.4
Chen, X.5
Guo, F.6
Lyssiotis, C.A.7
Aldape, K.8
Cantley, L.C.9
Lu, Z.10
-
149
-
-
84958073577
-
PKM2 and cancer: The function of PKM2 beyond glycolysis
-
26998110 4774429
-
Dong G, Mao Q, Xia W, Xu Y, Wang J, Xu L, Jiang F. PKM2 and cancer: The function of PKM2 beyond glycolysis. Oncol Lett. 2016;11(3):1980-6.
-
(2016)
Oncol Lett
, vol.11
, Issue.3
, pp. 1980-1986
-
-
Dong, G.1
Mao, Q.2
Xia, W.3
Xu, Y.4
Wang, J.5
Xu, L.6
Jiang, F.7
-
150
-
-
0034698178
-
Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc
-
10823814
-
Osthus RC, Shim H, Kim S, Li Q, Reddy R, Mukherjee M, Xu Y, Wonsey D, Lee LA, Dang CV. Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc. J Biol Chem. 2000;275(29):21797-800.
-
(2000)
J Biol Chem
, vol.275
, Issue.29
, pp. 21797-21800
-
-
Osthus, R.C.1
Shim, H.2
Kim, S.3
Li, Q.4
Reddy, R.5
Mukherjee, M.6
Xu, Y.7
Wonsey, D.8
Lee, L.A.9
Dang, C.V.10
-
151
-
-
35649014840
-
Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1
-
17785433 2169056
-
Kim JW, Gao P, Liu YC, Semenza GL, Dang CV. Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1. Mol Cell Biol. 2007;27(21):7381-93.
-
(2007)
Mol Cell Biol
, vol.27
, Issue.21
, pp. 7381-7393
-
-
Kim, J.W.1
Gao, P.2
Liu, Y.C.3
Semenza, G.L.4
Dang, C.V.5
-
152
-
-
84863229429
-
Modulation of glucose metabolism by CD44 contributes to antioxidant status and drug resistance in cancer cells
-
Tamada M, Nagano O, Tateyama S, Ohmura M, Yae T, Ishimoto T, Sugihara E, Onishi N, Yamamoto T, Yanagawa H, et al. Modulation of glucose metabolism by CD44 contributes to antioxidant status and drug resistance in cancer cells. Cancer Res. 2012;72(6):1438-1448.
-
(2012)
Cancer Res.
, vol.72
, Issue.6
, pp. 1438-1448
-
-
Tamada, M.1
Nagano, O.2
Tateyama, S.3
Ohmura, M.4
Yae, T.5
Ishimoto, T.6
Sugihara, E.7
Onishi, N.8
Yamamoto, T.9
Yanagawa, H.10
-
153
-
-
85019584181
-
Targeting Free Radicals in Oxidative Stress-Related Human Diseases
-
28551354
-
Poprac P, Jomova K, Simunkova M, Kollar V, Rhodes CJ, Valko M. Targeting Free Radicals in Oxidative Stress-Related Human Diseases. Trends Pharmacol Sci. 2017;38(7):592-607.
-
(2017)
Trends Pharmacol Sci
, vol.38
, Issue.7
, pp. 592-607
-
-
Poprac, P.1
Jomova, K.2
Simunkova, M.3
Kollar, V.4
Rhodes, C.J.5
Valko, M.6
-
154
-
-
84960172342
-
Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer
-
Camarda R, Zhou AY, Kohnz RA, Balakrishnan S, Mahieu C, Anderton B, Eyob H, Kajimura S, Tward A, Krings G, et al. Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer. Nat Med. 2016;22(4):427-432.
-
(2016)
Nat Med.
, vol.22
, Issue.4
, pp. 427-432
-
-
Camarda, R.1
Zhou, A.Y.2
Kohnz, R.A.3
Balakrishnan, S.4
Mahieu, C.5
Anderton, B.6
Eyob, H.7
Kajimura, S.8
Tward, A.9
Krings, G.10
-
155
-
-
85046740404
-
Metabolic Hallmarks of Metastasis Formation
-
[Epub ahead of print]
-
Elia I, Doglioni G, Fendt SM. Metabolic Hallmarks of Metastasis Formation. Trends Cell Biol. 2018. https://doi.org/10.1016/j.tcb.2018.04.002. [Epub ahead of print].
-
(2018)
Trends Cell Biol.
-
-
Elia, I.1
Doglioni, G.2
Fendt, S.M.3
-
156
-
-
84906960365
-
C-Myc programs fatty acid metabolism and dictates acetyl-CoA abundance and fate
-
Edmunds LR, Sharma L, Kang A, Lu J, Vockley J, Basu S, Uppala R, Goetzman ES, Beck ME, Scott D, et al. c-Myc programs fatty acid metabolism and dictates acetyl-CoA abundance and fate. J Biol Chem. 2014;289(36):25382-25392.
-
(2014)
J Biol Chem
, vol.289
, Issue.36
, pp. 25382-25392
-
-
Edmunds, L.R.1
Sharma, L.2
Kang, A.3
Lu, J.4
Vockley, J.5
Basu, S.6
Uppala, R.7
Goetzman, E.S.8
Beck, M.E.9
Scott, D.10
-
157
-
-
85016165255
-
Targeting metastasis-initiating cells through the fatty acid receptor CD36
-
Pascual G, Avgustinova A, Mejetta S, Martin M, Castellanos A, Attolini CS, Berenguer A, Prats N, Toll A, Hueto JA, et al. Targeting metastasis-initiating cells through the fatty acid receptor CD36. Nature. 2017;541(7635):41-45.
-
(2017)
Nature
, vol.541
, Issue.7635
, pp. 41-45
-
-
Pascual, G.1
Avgustinova, A.2
Mejetta, S.3
Martin, M.4
Castellanos, A.5
Attolini, C.S.6
Berenguer, A.7
Prats, N.8
Toll, A.9
Hueto, J.A.10
-
158
-
-
85041606995
-
Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis
-
29398710
-
Ladanyi A, Mukherjee A, Kenny HA, Johnson A, Mitra AK, Sundaresan S, Nieman KM, Pascual G, Benitah SA, Montag A, et al. Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis. Oncogene. 2018;37(17):2285-301.
-
(2018)
Oncogene
, vol.37
, Issue.17
, pp. 2285-2301
-
-
Ladanyi, A.1
Mukherjee, A.2
Kenny, H.A.3
Johnson, A.4
Mitra, A.K.5
Sundaresan, S.6
Nieman, K.M.7
Pascual, G.8
Benitah, S.A.9
Montag, A.10
-
159
-
-
85046635283
-
Prevention of hepatocellular carcinoma by targeting MYCN-positive liver cancer stem cells with acyclic retinoid
-
29686061 5949003
-
Qin XY, Suzuki H, Honda M, Okada H, Kaneko S, Inoue I, Ebisui E, Hashimoto K, Carninci P, Kanki K, et al. Prevention of hepatocellular carcinoma by targeting MYCN-positive liver cancer stem cells with acyclic retinoid. Proc Natl Acad Sci U S A. 2018;115(19):4969-4974.
-
(2018)
Proc Natl Acad Sci U S A
, vol.115
, Issue.19
, pp. 4969-4974
-
-
Qin, X.Y.1
Suzuki, H.2
Honda, M.3
Okada, H.4
Kaneko, S.5
Inoue, I.6
Ebisui, E.7
Hashimoto, K.8
Carninci, P.9
Kanki, K.10
-
160
-
-
85049652092
-
How to eliminate MYCN-positive hepatic cancer stem cells to prevent the recurrence?
-
29941608
-
Yoshida GJ. How to eliminate MYCN-positive hepatic cancer stem cells to prevent the recurrence? Proc Natl Acad Sci U S A. 2018;115(28):E6388-E6389.
-
(2018)
Proc Natl Acad Sci U S A
, vol.115
, Issue.28
, pp. E6388-E6389
-
-
Yoshida, G.J.1
-
161
-
-
84922784813
-
Deregulated Myc requires MondoA/Mlx for metabolic reprogramming and tumorigenesis
-
Carroll PA, Diolaiti D, McFerrin L, Gu H, Djukovic D, Du J, Cheng PF, Anderson S, Ulrich M, Hurley JB, et al. Deregulated Myc requires MondoA/Mlx for metabolic reprogramming and tumorigenesis. Cancer Cell. 2015;27(2):271-285.
-
(2015)
Cancer Cell
, vol.27
, Issue.2
, pp. 271-285
-
-
Carroll, P.A.1
Diolaiti, D.2
McFerrin, L.3
Gu, H.4
Djukovic, D.5
Du, J.6
Cheng, P.F.7
Anderson, S.8
Ulrich, M.9
Hurley, J.B.10
-
162
-
-
85029515651
-
Global metabolic reprogramming of colorectal cancer occurs at adenoma stage and is induced by MYC
-
Satoh K, Yachida S, Sugimoto M, Oshima M, Nakagawa T, Akamoto S, Tabata S, Saitoh K, Kato K, Sato S, et al. Global metabolic reprogramming of colorectal cancer occurs at adenoma stage and is induced by MYC. Proc Natl Acad Sci U S A. 2017;114(37):E7697-E7706.
-
(2017)
Proc Natl Acad Sci U S A
, vol.114
, Issue.37
, pp. E7697-E7706
-
-
Satoh, K.1
Yachida, S.2
Sugimoto, M.3
Oshima, M.4
Nakagawa, T.5
Akamoto, S.6
Tabata, S.7
Saitoh, K.8
Kato, K.9
Sato, S.10
-
163
-
-
48849089915
-
Global regulation of nucleotide biosynthetic genes by c-Myc
-
e2722 18628958 2444028
-
Liu YC, Li F, Handler J, Huang CR, Xiang Y, Neretti N, Sedivy JM, Zeller KI, Dang CV. Global regulation of nucleotide biosynthetic genes by c-Myc. PLoS One. 2008;3(7):e2722.
-
(2008)
PLoS One
, vol.3
, Issue.7
-
-
Liu, Y.C.1
Li, F.2
Handler, J.3
Huang, C.R.4
Xiang, Y.5
Neretti, N.6
Sedivy, J.M.7
Zeller, K.I.8
Dang, C.V.9
-
164
-
-
48849108368
-
Control of nucleotide biosynthesis by the MYC oncoprotein
-
18682683 3118556
-
McMahon SB. Control of nucleotide biosynthesis by the MYC oncoprotein. Cell Cycle. 2008;7(15):2275-6.
-
(2008)
Cell Cycle
, vol.7
, Issue.15
, pp. 2275-2276
-
-
McMahon, S.B.1
-
165
-
-
85044948786
-
Thymidine phosphorylase in cancer aggressiveness and chemoresistance
-
29604437
-
Furukawa T, Tabata S, Yamamoto M, Kawahara K, Shinsato Y, Minami K, Shimokawa M, Akiyama SI. Thymidine phosphorylase in cancer aggressiveness and chemoresistance. Pharmacol Res. 2018;132:15-20.
-
(2018)
Pharmacol Res
, vol.132
, pp. 15-20
-
-
Furukawa, T.1
Tabata, S.2
Yamamoto, M.3
Kawahara, K.4
Shinsato, Y.5
Minami, K.6
Shimokawa, M.7
Akiyama, S.I.8
-
166
-
-
84978984470
-
Clinical development of cancer therapeutics that target metabolism
-
26428335
-
Clem BF, O'Neal J, Klarer AC, Telang S, Chesney J. Clinical development of cancer therapeutics that target metabolism. QJM. 2016;109(6):367-72.
-
(2016)
QJM
, vol.109
, Issue.6
, pp. 367-372
-
-
Clem, B.F.1
O'Neal, J.2
Klarer, A.C.3
Telang, S.4
Chesney, J.5
-
167
-
-
84978900742
-
Glutaminolysis as a target for cancer therapy
-
26592449
-
Jin L, Alesi GN, Kang S. Glutaminolysis as a target for cancer therapy. Oncogene. 2016;35(28):3619-25.
-
(2016)
Oncogene
, vol.35
, Issue.28
, pp. 3619-3625
-
-
Jin, L.1
Alesi, G.N.2
Kang, S.3
-
168
-
-
85012889903
-
Glutaminolysis gets the spotlight in cancer
-
28053289
-
Herranz D. Glutaminolysis gets the spotlight in cancer. Oncotarget. 2017;8(7):10761-2.
-
(2017)
Oncotarget
, vol.8
, Issue.7
, pp. 10761-10762
-
-
Herranz, D.1
-
169
-
-
84930392977
-
Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis
-
Xiang Y, Stine ZE, Xia J, Lu Y, O'Connor RS, Altman BJ, Hsieh AL, Gouw AM, Thomas AG, Gao P, et al. Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis. J Clin Invest. 2015;125(6):2293-2306.
-
(2015)
J Clin Invest
, vol.125
, Issue.6
, pp. 2293-2306
-
-
Xiang, Y.1
Stine, Z.E.2
Xia, J.3
Lu, Y.4
O'Connor, R.S.5
Altman, B.J.6
Hsieh, A.L.7
Gouw, A.M.8
Thomas, A.G.9
Gao, P.10
-
170
-
-
84904645105
-
Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer
-
24523301
-
Gross MI, Demo SD, Dennison JB, Chen L, Chernov-Rogan T, Goyal B, Janes JR, Laidig GJ, Lewis ER, Li J, et al. Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer. Mol Cancer Ther. 2014;13(4):890-901.
-
(2014)
Mol Cancer Ther
, vol.13
, Issue.4
, pp. 890-901
-
-
Gross, M.I.1
Demo, S.D.2
Dennison, J.B.3
Chen, L.4
Chernov-Rogan, T.5
Goyal, B.6
Janes, J.R.7
Laidig, G.J.8
Lewis, E.R.9
Li, J.10
-
171
-
-
85026230339
-
Glutaminase inhibitor CB-839 synergizes with carfilzomib in resistant multiple myeloma cells
-
28415782 5482623
-
Thompson RM, Dytfeld D, Reyes L, Robinson RM, Smith B, Manevich Y, Jakubowiak A, Komarnicki M, Przybylowicz-Chalecka A, Szczepaniak T, et al. Glutaminase inhibitor CB-839 synergizes with carfilzomib in resistant multiple myeloma cells. Oncotarget. 2017;8(22):35863-35876.
-
(2017)
Oncotarget
, vol.8
, Issue.22
, pp. 35863-35876
-
-
Thompson, R.M.1
Dytfeld, D.2
Reyes, L.3
Robinson, R.M.4
Smith, B.5
Manevich, Y.6
Jakubowiak, A.7
Komarnicki, M.8
Przybylowicz-Chalecka, A.9
Szczepaniak, T.10
-
172
-
-
85043699777
-
Characterization of the interactions of potent allosteric inhibitors with glutaminase C, a key enzyme in cancer cell glutamine metabolism
-
29317493
-
Huang Q, Stalnecker C, Zhang C, McDermott LA, Iyer P, O'Neill J, Reimer S, Cerione RA, Katt WP. Characterization of the interactions of potent allosteric inhibitors with glutaminase C, a key enzyme in cancer cell glutamine metabolism. J Biol Chem. 2018;293(10):3535-45.
-
(2018)
J Biol Chem
, vol.293
, Issue.10
, pp. 3535-3545
-
-
Huang, Q.1
Stalnecker, C.2
Zhang, C.3
McDermott, L.A.4
Iyer, P.5
O'Neill, J.6
Reimer, S.7
Cerione, R.A.8
Katt, W.P.9
-
173
-
-
78650824534
-
Ubiquitin-like protein conjugation and the ubiquitin-proteasome system as drug targets
-
21151032
-
Bedford L, Lowe J, Dick LR, Mayer RJ, Brownell JE. Ubiquitin-like protein conjugation and the ubiquitin-proteasome system as drug targets. Nat Rev Drug Discov. 2011;10(1):29-46.
-
(2011)
Nat Rev Drug Discov
, vol.10
, Issue.1
, pp. 29-46
-
-
Bedford, L.1
Lowe, J.2
Dick, L.R.3
Mayer, R.J.4
Brownell, J.E.5
-
174
-
-
85033593401
-
Proteasome-associated deubiquitinases and cancer
-
29134486 5721125
-
Mofers A, Pellegrini P, Linder S, D'Arcy P. Proteasome-associated deubiquitinases and cancer. Cancer Metastasis Rev. 2017;36(4):635-53.
-
(2017)
Cancer Metastasis Rev
, vol.36
, Issue.4
, pp. 635-653
-
-
Mofers, A.1
Pellegrini, P.2
Linder, S.3
D'Arcy, P.4
-
175
-
-
85041553883
-
A small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatment
-
Hyer ML, Milhollen MA, Ciavarri J, Fleming P, Traore T, Sappal D, Huck J, Shi J, Gavin J, Brownell J, et al. A small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatment. Nat Med. 2018;24(2):186-193.
-
(2018)
Nat Med.
, vol.24
, Issue.2
, pp. 186-193
-
-
Hyer, M.L.1
Ma, M.2
Ciavarri, J.3
Fleming, P.4
Traore, T.5
Sappal, D.6
Huck, J.7
Shi, J.8
Gavin, J.9
Brownell, J.10
-
176
-
-
85016923851
-
Proteasome expression and activity in cancer and cancer stem cells
-
28345458
-
Voutsadakis IA. Proteasome expression and activity in cancer and cancer stem cells. Tumour Biol. 2017;39(3):1010428317692248.
-
(2017)
Tumour Biol
, vol.39
, Issue.3
, pp. 248
-
-
Voutsadakis, I.A.1
-
177
-
-
84940479138
-
Regulating the Regulators: Recent Revelations in the Control of E3 Ubiquitin Ligases
-
26187467 4571856
-
Vittal V, Stewart MD, Brzovic PS, Klevit RE. Regulating the Regulators: Recent Revelations in the Control of E3 Ubiquitin Ligases. J Biol Chem. 2015;290(35):21244-51.
-
(2015)
J Biol Chem
, vol.290
, Issue.35
, pp. 21244-21251
-
-
Vittal, V.1
Stewart, M.D.2
Brzovic, P.S.3
Klevit, R.E.4
-
178
-
-
80051978811
-
The predator becomes the prey: Regulating the ubiquitin system by ubiquitylation and degradation
-
21860393 3545438
-
Weissman AM, Shabek N, Ciechanover A. The predator becomes the prey: regulating the ubiquitin system by ubiquitylation and degradation. Nat Rev Mol Cell Biol. 2011;12(9):605-20.
-
(2011)
Nat Rev Mol Cell Biol
, vol.12
, Issue.9
, pp. 605-620
-
-
Weissman, A.M.1
Shabek, N.2
Ciechanover, A.3
-
179
-
-
85028121020
-
Role of the ubiquitin ligase Fbw7 in cancer progression
-
22124735
-
Cheng Y, Li G. Role of the ubiquitin ligase Fbw7 in cancer progression. Cancer Metastasis Rev. 2012;31(1-2):75-87.
-
(2012)
Cancer Metastasis Rev
, vol.31
, Issue.1-2
, pp. 75-87
-
-
Cheng, Y.1
Li, G.2
-
180
-
-
84875498138
-
Role of SKP1-CUL1-F-box-protein (SCF) E3 ubiquitin ligases in skin cancer
-
23522382
-
Xie CM, Wei W, Sun Y. Role of SKP1-CUL1-F-box-protein (SCF) E3 ubiquitin ligases in skin cancer. J Genet Genomics. 2013;40(3):97-106.
-
(2013)
J Genet Genomics
, vol.40
, Issue.3
, pp. 97-106
-
-
Xie, C.M.1
Wei, W.2
Sun, Y.3
-
181
-
-
84877107994
-
Genetically engineered mouse models for functional studies of SKP1-CUL1-F-box-protein (SCF) E3 ubiquitin ligases
-
23528706 3641602
-
Zhou W, Wei W, Sun Y. Genetically engineered mouse models for functional studies of SKP1-CUL1-F-box-protein (SCF) E3 ubiquitin ligases. Cell Res. 2013;23(5):599-619.
-
(2013)
Cell Res
, vol.23
, Issue.5
, pp. 599-619
-
-
Zhou, W.1
Wei, W.2
Sun, Y.3
-
182
-
-
85018342631
-
Enzyme-substrate relationships in the ubiquitin system: Approaches for identifying substrates of ubiquitin ligases
-
28455558
-
O'Connor HF, Huibregtse JM. Enzyme-substrate relationships in the ubiquitin system: approaches for identifying substrates of ubiquitin ligases. Cell Mol Life Sci. 2017;74(18):3363-75.
-
(2017)
Cell Mol Life Sci
, vol.74
, Issue.18
, pp. 3363-3375
-
-
O'Connor, H.F.1
Huibregtse, J.M.2
-
183
-
-
38549086019
-
FBW7 ubiquitin ligase: A tumour suppressor at the crossroads of cell division, growth and differentiation
-
18094723
-
Welcker M, Clurman BE. FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat Rev Cancer. 2008;8(2):83-93.
-
(2008)
Nat Rev Cancer
, vol.8
, Issue.2
, pp. 83-93
-
-
Welcker, M.1
Clurman, B.E.2
-
184
-
-
17044370346
-
Regulation of the cell cycle by SCF-type ubiquitin ligases
-
15840441
-
Nakayama KI, Nakayama K. Regulation of the cell cycle by SCF-type ubiquitin ligases. Semin Cell Dev Biol. 2005;16(3):323-33.
-
(2005)
Semin Cell Dev Biol
, vol.16
, Issue.3
, pp. 323-333
-
-
Nakayama, K.I.1
Nakayama, K.2
-
185
-
-
84978898661
-
To wake up cancer stem cells, or to let them sleep, that is the question
-
27116333 4946711
-
Takeishi S, Nakayama KI. To wake up cancer stem cells, or to let them sleep, that is the question. Cancer Sci. 2016;107(7):875-81.
-
(2016)
Cancer Sci
, vol.107
, Issue.7
, pp. 875-881
-
-
Takeishi, S.1
Nakayama, K.I.2
-
186
-
-
0017401702
-
Effects of the mitotic cell-cycle mutation cdc4 on yeast meiosis
-
328339 1213672
-
Simchen G, Hirschberg J. Effects of the mitotic cell-cycle mutation cdc4 on yeast meiosis. Genetics. 1977;86(1):57-72.
-
(1977)
Genetics
, vol.86
, Issue.1
, pp. 57-72
-
-
Simchen, G.1
Hirschberg, J.2
-
187
-
-
6944227551
-
A nucleolar isoform of the Fbw7 ubiquitin ligase regulates c-Myc and cell size
-
15498494
-
Welcker M, Orian A, Grim JE, Eisenman RN, Clurman BE. A nucleolar isoform of the Fbw7 ubiquitin ligase regulates c-Myc and cell size. Curr Biol. 2004;14(20):1852-7.
-
(2004)
Curr Biol
, vol.14
, Issue.20
, pp. 1852-1857
-
-
Welcker, M.1
Orian, A.2
Grim, J.E.3
Eisenman, R.N.4
Clurman, B.E.5
-
188
-
-
9644279589
-
Recognition of phosphodegron motifs in human cyclin e by the SCF(Fbw7) ubiquitin ligase
-
15364936
-
Ye X, Nalepa G, Welcker M, Kessler BM, Spooner E, Qin J, Elledge SJ, Clurman BE, Harper JW. Recognition of phosphodegron motifs in human cyclin E by the SCF(Fbw7) ubiquitin ligase. J Biol Chem. 2004;279(48):50110-9.
-
(2004)
J Biol Chem
, vol.279
, Issue.48
, pp. 50110-50119
-
-
Ye, X.1
Nalepa, G.2
Welcker, M.3
Kessler, B.M.4
Spooner, E.5
Qin, J.6
Elledge, S.J.7
Clurman, B.E.8
Harper, J.W.9
-
189
-
-
33846266628
-
Fbw7 isoform interaction contributes to cyclin e proteolysis
-
17189384
-
Zhang W, Koepp DM. Fbw7 isoform interaction contributes to cyclin E proteolysis. Mol Cancer Res. 2006;4(12):935-43.
-
(2006)
Mol Cancer Res
, vol.4
, Issue.12
, pp. 935-943
-
-
Zhang, W.1
Koepp, D.M.2
-
190
-
-
78149456945
-
WD40 repeat propellers define a ubiquitin-binding domain that regulates turnover of F box proteins
-
21070969 3266742
-
Pashkova N, Gakhar L, Winistorfer SC, Yu L, Ramaswamy S, Piper RC. WD40 repeat propellers define a ubiquitin-binding domain that regulates turnover of F box proteins. Mol Cell. 2010;40(3):433-43.
-
(2010)
Mol Cell
, vol.40
, Issue.3
, pp. 433-443
-
-
Pashkova, N.1
Gakhar, L.2
Winistorfer, S.C.3
Yu, L.4
Ramaswamy, S.5
Piper, R.C.6
-
191
-
-
65949107856
-
P53-Altered FBXW7 expression determines poor prognosis in gastric cancer cases
-
19366810
-
Yokobori T, Mimori K, Iwatsuki M, Ishii H, Onoyama I, Fukagawa T, Kuwano H, Nakayama KI, Mori M. p53-Altered FBXW7 expression determines poor prognosis in gastric cancer cases. Cancer Res. 2009;69(9):3788-94.
-
(2009)
Cancer Res
, vol.69
, Issue.9
, pp. 3788-3794
-
-
Yokobori, T.1
Mimori, K.2
Iwatsuki, M.3
Ishii, H.4
Onoyama, I.5
Fukagawa, T.6
Kuwano, H.7
Nakayama, K.I.8
Mori, M.9
-
192
-
-
2942614705
-
Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7
-
15103331 424394
-
Yada M, Hatakeyama S, Kamura T, Nishiyama M, Tsunematsu R, Imaki H, Ishida N, Okumura F, Nakayama K, Nakayama KI. Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7. EMBO J. 2004;23(10):2116-25.
-
(2004)
EMBO J
, vol.23
, Issue.10
, pp. 2116-2125
-
-
Yada, M.1
Hatakeyama, S.2
Kamura, T.3
Nishiyama, M.4
Tsunematsu, R.5
Imaki, H.6
Ishida, N.7
Okumura, F.8
Nakayama, K.9
Nakayama, K.I.10
-
193
-
-
36549071481
-
Conditional inactivation of Fbxw7 impairs cell-cycle exit during T cell differentiation and results in lymphomatogenesis
-
17984302 2118521
-
Onoyama I, Tsunematsu R, Matsumoto A, Kimura T, de Alboran IM, Nakayama K, Nakayama KI. Conditional inactivation of Fbxw7 impairs cell-cycle exit during T cell differentiation and results in lymphomatogenesis. J Exp Med. 2007;204(12):2875-88.
-
(2007)
J Exp Med
, vol.204
, Issue.12
, pp. 2875-2888
-
-
Onoyama, I.1
Tsunematsu, R.2
Matsumoto, A.3
Kimura, T.4
De Alboran, I.M.5
Nakayama, K.6
Nakayama, K.I.7
-
194
-
-
42149132696
-
Fbxw7 acts as a critical fail-safe against premature loss of hematopoietic stem cells and development of T-ALL
-
18367647 2335330
-
Matsuoka S, Oike Y, Onoyama I, Iwama A, Arai F, Takubo K, Mashimo Y, Oguro H, Nitta E, Ito K, et al. Fbxw7 acts as a critical fail-safe against premature loss of hematopoietic stem cells and development of T-ALL. Genes Dev. 2008;22(8):986-991.
-
(2008)
Genes Dev
, vol.22
, Issue.8
, pp. 986-991
-
-
Matsuoka, S.1
Oike, Y.2
Onoyama, I.3
Iwama, A.4
Arai, F.5
Takubo, K.6
Mashimo, Y.7
Oguro, H.8
Nitta, E.9
Ito, K.10
-
195
-
-
85014911930
-
The NOTCH1-MYC highway toward T-cell acute lymphoblastic leukemia
-
28115368
-
Sanchez-Martin M, Ferrando A. The NOTCH1-MYC highway toward T-cell acute lymphoblastic leukemia. Blood. 2017;129(9):1124-33.
-
(2017)
Blood
, vol.129
, Issue.9
, pp. 1124-1133
-
-
Sanchez-Martin, M.1
Ferrando, A.2
-
196
-
-
80052289298
-
P57 is required for quiescence and maintenance of adult hematopoietic stem cells
-
21885021
-
Matsumoto A, Takeishi S, Kanie T, Susaki E, Onoyama I, Tateishi Y, Nakayama K, Nakayama KI. p57 is required for quiescence and maintenance of adult hematopoietic stem cells. Cell Stem Cell. 2011;9(3):262-71.
-
(2011)
Cell Stem Cell
, vol.9
, Issue.3
, pp. 262-271
-
-
Matsumoto, A.1
Takeishi, S.2
Kanie, T.3
Susaki, E.4
Onoyama, I.5
Tateishi, Y.6
Nakayama, K.7
Nakayama, K.I.8
-
197
-
-
80052276418
-
Breaking the cell cycle of HSCs by p57 and friends
-
21885016
-
Tesio M, Trumpp A. Breaking the cell cycle of HSCs by p57 and friends. Cell Stem Cell. 2011;9(3):187-92.
-
(2011)
Cell Stem Cell
, vol.9
, Issue.3
, pp. 187-192
-
-
Tesio, M.1
Trumpp, A.2
-
198
-
-
84878240136
-
Molecular regulation of stem cell quiescence
-
23698583
-
Cheung TH, Rando TA. Molecular regulation of stem cell quiescence. Nat Rev Mol Cell Biol. 2013;14(6):329-40.
-
(2013)
Nat Rev Mol Cell Biol
, vol.14
, Issue.6
, pp. 329-340
-
-
Cheung, T.H.1
Rando, T.A.2
-
199
-
-
54049087334
-
Notch-dependent cell cycle arrest and apoptosis in mouse embryonic fibroblasts lacking Fbxw7
-
18641686
-
Ishikawa Y, Onoyama I, Nakayama KI, Nakayama K. Notch-dependent cell cycle arrest and apoptosis in mouse embryonic fibroblasts lacking Fbxw7. Oncogene. 2008;27(47):6164-74.
-
(2008)
Oncogene
, vol.27
, Issue.47
, pp. 6164-6174
-
-
Ishikawa, Y.1
Onoyama, I.2
Nakayama, K.I.3
Nakayama, K.4
-
200
-
-
84859496041
-
Notch inhibition as a promising new approach to cancer therapy
-
22399357 3361718
-
Purow B. Notch inhibition as a promising new approach to cancer therapy. Adv Exp Med Biol. 2012;727:305-19.
-
(2012)
Adv Exp Med Biol
, vol.727
, pp. 305-319
-
-
Purow, B.1
-
201
-
-
55949136859
-
Anoikis resistance and tumor metastasis
-
18579285
-
Simpson CD, Anyiwe K, Schimmer AD. Anoikis resistance and tumor metastasis. Cancer Lett. 2008;272(2):177-85.
-
(2008)
Cancer Lett
, vol.272
, Issue.2
, pp. 177-185
-
-
Simpson, C.D.1
Anyiwe, K.2
Schimmer, A.D.3
-
202
-
-
84897085768
-
Roles of F-box proteins in cancer
-
24658274 4306233
-
Wang Z, Liu P, Inuzuka H, Wei W. Roles of F-box proteins in cancer. Nat Rev Cancer. 2014;14(4):233-47.
-
(2014)
Nat Rev Cancer
, vol.14
, Issue.4
, pp. 233-247
-
-
Wang, Z.1
Liu, P.2
Inuzuka, H.3
Wei, W.4
-
203
-
-
77950090066
-
Complex regulation of cell-cycle inhibitors by Fbxw7 in mouse embryonic fibroblasts
-
20023701
-
Masuda K, Ishikawa Y, Onoyama I, Unno M, de Alboran IM, Nakayama KI, Nakayama K. Complex regulation of cell-cycle inhibitors by Fbxw7 in mouse embryonic fibroblasts. Oncogene. 2010;29(12):1798-809.
-
(2010)
Oncogene
, vol.29
, Issue.12
, pp. 1798-1809
-
-
Masuda, K.1
Ishikawa, Y.2
Onoyama, I.3
Unno, M.4
De Alboran, I.M.5
Nakayama, K.I.6
Nakayama, K.7
-
204
-
-
84861189396
-
Tumor suppressor functions of FBW7 in cancer development and progression
-
22673505 3372850
-
Wang Z, Inuzuka H, Zhong J, Wan L, Fukushima H, Sarkar FH, Wei W. Tumor suppressor functions of FBW7 in cancer development and progression. FEBS Lett. 2012;586(10):1409-18.
-
(2012)
FEBS Lett
, vol.586
, Issue.10
, pp. 1409-1418
-
-
Wang, Z.1
Inuzuka, H.2
Zhong, J.3
Wan, L.4
Fukushima, H.5
Sarkar, F.H.6
Wei, W.7
-
205
-
-
85013304766
-
E3 ubiquitin ligase FBW7alpha inhibits cholangiocarcinoma cell proliferation by downregulating c-Myc and cyclin e
-
28184929
-
Li M, Ouyang L, Zheng Z, Xiang D, Ti A, Li L, Dan Y, Yu C, Li W. E3 ubiquitin ligase FBW7alpha inhibits cholangiocarcinoma cell proliferation by downregulating c-Myc and cyclin E. Oncol Rep. 2017;37(3):1627-36.
-
(2017)
Oncol Rep
, vol.37
, Issue.3
, pp. 1627-1636
-
-
Li, M.1
Ouyang, L.2
Zheng, Z.3
Xiang, D.4
Ti, A.5
Li, L.6
Dan, Y.7
Yu, C.8
Li, W.9
-
206
-
-
84961288227
-
F-box protein FBXW7 inhibits cancer metastasis in a non-cell-autonomous manner
-
25555218 4319427
-
Yumimoto K, Akiyoshi S, Ueo H, Sagara Y, Onoyama I, Ohno S, Mori M, Mimori K, Nakayama KI. F-box protein FBXW7 inhibits cancer metastasis in a non-cell-autonomous manner. J Clin Invest. 2015;125(2):621-35.
-
(2015)
J Clin Invest
, vol.125
, Issue.2
, pp. 621-635
-
-
Yumimoto, K.1
Akiyoshi, S.2
Ueo, H.3
Sagara, Y.4
Onoyama, I.5
Ohno, S.6
Mori, M.7
Mimori, K.8
Nakayama, K.I.9
-
207
-
-
84959422566
-
The tumor microenvironment and Immunoscore are critical determinants of dissemination to distant metastasis
-
Mlecnik B, Bindea G, Kirilovsky A, Angell HK, Obenauf AC, Tosolini M, Church SE, Maby P, Vasaturo A, Angelova M, et al. The tumor microenvironment and Immunoscore are critical determinants of dissemination to distant metastasis. Sci Transl Med. 2016;8(327):327ra326.
-
(2016)
Sci Transl Med.
, vol.8
, Issue.327
, pp. 327ra326
-
-
Mlecnik, B.1
Bindea, G.2
Kirilovsky, A.3
Angell, H.K.4
Obenauf, A.C.5
Tosolini, M.6
Church, S.E.7
Maby, P.8
Vasaturo, A.9
Angelova, M.10
-
208
-
-
84958159750
-
Regulating Fbw7 on the road to cancer
-
26459133
-
Xu W, Taranets L, Popov N. Regulating Fbw7 on the road to cancer. Semin Cancer Biol. 2016;36:62-70.
-
(2016)
Semin Cancer Biol
, vol.36
, pp. 62-70
-
-
Xu, W.1
Taranets, L.2
Popov, N.3
-
209
-
-
4644318882
-
Tyrosine kinase inhibitors in renal cell carcinoma
-
15448033
-
Potti A, George DJ. Tyrosine kinase inhibitors in renal cell carcinoma. Clin Cancer Res. 2004;10(18 Pt 2):6371S-6S.
-
(2004)
Clin Cancer Res
, vol.10
, Issue.18
, pp. 6371S-6376S
-
-
Potti, A.1
George, D.J.2
-
210
-
-
33745459794
-
Renal cell carcinoma and the use of sorafenib
-
18360584 1661649
-
Larkin JM, Eisen T. Renal cell carcinoma and the use of sorafenib. Ther Clin Risk Manag. 2006;2(1):87-98.
-
(2006)
Ther Clin Risk Manag
, vol.2
, Issue.1
, pp. 87-98
-
-
Larkin, J.M.1
Eisen, T.2
-
211
-
-
33646345376
-
Ubiquitin ligases: Cell-cycle control and cancer
-
16633365
-
Nakayama KI, Nakayama K. Ubiquitin ligases: cell-cycle control and cancer. Nat Rev Cancer. 2006;6(5):369-81.
-
(2006)
Nat Rev Cancer
, vol.6
, Issue.5
, pp. 369-381
-
-
Nakayama, K.I.1
Nakayama, K.2
-
212
-
-
67349136004
-
Mcl-1 is a potential therapeutic target in multiple types of cancer
-
19099185
-
Akgul C. Mcl-1 is a potential therapeutic target in multiple types of cancer. Cell Mol Life Sci. 2009;66(8):1326-36.
-
(2009)
Cell Mol Life Sci
, vol.66
, Issue.8
, pp. 1326-1336
-
-
Akgul, C.1
-
213
-
-
79952261405
-
SCF(FBW7) regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction
-
21368833 3076007
-
Inuzuka H, Shaik S, Onoyama I, Gao D, Tseng A, Maser RS, Zhai B, Wan L, Gutierrez A, Lau AW, et al. SCF(FBW7) regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction. Nature. 2011;471(7336):104-109.
-
(2011)
Nature
, vol.471
, Issue.7336
, pp. 104-109
-
-
Inuzuka, H.1
Shaik, S.2
Onoyama, I.3
Gao, D.4
Tseng, A.5
Maser, R.S.6
Zhai, B.7
Wan, L.8
Gutierrez, A.9
Lau, A.W.10
-
214
-
-
84908381929
-
Role of Fbxw7 in the maintenance of normal stem cells and cancer-initiating cells
-
24853181 4453837
-
Takeishi S, Nakayama KI. Role of Fbxw7 in the maintenance of normal stem cells and cancer-initiating cells. Br J Cancer. 2014;111(6):1054-9.
-
(2014)
Br J Cancer
, vol.111
, Issue.6
, pp. 1054-1059
-
-
Takeishi, S.1
Nakayama, K.I.2
-
215
-
-
84958114871
-
Fbw7 and its counteracting forces in stem cells and cancer: Oncoproteins in the balance
-
26410034
-
Cremona CA, Sancho R, Diefenbacher ME, Behrens A. Fbw7 and its counteracting forces in stem cells and cancer: Oncoproteins in the balance. Semin Cancer Biol. 2016;36:52-61.
-
(2016)
Semin Cancer Biol
, vol.36
, pp. 52-61
-
-
Cremona, C.A.1
Sancho, R.2
Diefenbacher, M.E.3
Behrens, A.4
-
216
-
-
52549087785
-
Cancer stem cells in solid tumours: Accumulating evidence and unresolved questions
-
18784658
-
Visvader JE, Lindeman GJ. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer. 2008;8(10):755-68.
-
(2008)
Nat Rev Cancer
, vol.8
, Issue.10
, pp. 755-768
-
-
Visvader, J.E.1
Lindeman, G.J.2
-
217
-
-
85015610004
-
The secret life of quiescent cancer stem cells
-
e968067 27308385
-
Zeuner A. The secret life of quiescent cancer stem cells. Mol Cell Oncol. 2015;2(1):e968067.
-
(2015)
Mol Cell Oncol
, vol.2
, Issue.1
-
-
Zeuner, A.1
-
218
-
-
84978765993
-
Cancer Stem Cell Quiescence and Plasticity as Major Challenges in Cancer Therapy
-
27418931 4932171
-
Chen W, Dong J, Haiech J, Kilhoffer MC, Zeniou M. Cancer Stem Cell Quiescence and Plasticity as Major Challenges in Cancer Therapy. Stem Cells Int. 2016;2016:1740936.
-
(2016)
Stem Cells Int
, vol.2016
, pp. 1740936
-
-
Chen, W.1
Dong, J.2
Haiech, J.3
Kilhoffer, M.C.4
Zeniou, M.5
-
219
-
-
0035110959
-
Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: A novel target mechanism concept for pharmacokinetic modulating chemotherapy
-
11221829
-
Yoshikawa R, Kusunoki M, Yanagi H, Noda M, Furuyama JI, Yamamura T, Hashimoto-Tamaoki T. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy. Cancer Res. 2001;61(3):1029-37.
-
(2001)
Cancer Res
, vol.61
, Issue.3
, pp. 1029-1037
-
-
Yoshikawa, R.1
Kusunoki, M.2
Yanagi, H.3
Noda, M.4
Furuyama, J.I.5
Yamamura, T.6
Hashimoto-Tamaoki, T.7
-
220
-
-
0043095544
-
Cell cycle phase-specific chemotherapy: Computational methods for guiding treatment
-
12548007
-
Gardner SN. Cell cycle phase-specific chemotherapy: computational methods for guiding treatment. Cell Cycle. 2002;1(6):369-74.
-
(2002)
Cell Cycle
, vol.1
, Issue.6
, pp. 369-374
-
-
Gardner, S.N.1
-
221
-
-
0842308823
-
Progress in treatment of small-cell lung cancer: Role of CPT-11
-
14676791 2395289
-
Saijo N. Progress in treatment of small-cell lung cancer: role of CPT-11. Br J Cancer. 2003;89(12):2178-83.
-
(2003)
Br J Cancer
, vol.89
, Issue.12
, pp. 2178-2183
-
-
Saijo, N.1
-
222
-
-
77954187741
-
DNA topoisomerases and their poisoning by anticancer and antibacterial drugs
-
20534341
-
Pommier Y, Leo E, Zhang H, Marchand C. DNA topoisomerases and their poisoning by anticancer and antibacterial drugs. Chem Biol. 2010;17(5):421-33.
-
(2010)
Chem Biol
, vol.17
, Issue.5
, pp. 421-433
-
-
Pommier, Y.1
Leo, E.2
Zhang, H.3
Marchand, C.4
-
223
-
-
84893664923
-
Cancer stem cell characteristics, ALDH1 expression in the invasive front of nasopharyngeal carcinoma
-
24248285
-
Luo WR, Yao KT. Cancer stem cell characteristics, ALDH1 expression in the invasive front of nasopharyngeal carcinoma. Virchows Arch. 2014;464(1):35-43.
-
(2014)
Virchows Arch
, vol.464
, Issue.1
, pp. 35-43
-
-
Luo, W.R.1
Yao, K.T.2
-
224
-
-
85001790619
-
Prognostic impact of CD44-positive cancer stem-like cells at the invasive front of gastric cancer
-
27931044
-
Kodama H, Murata S, Ishida M, Yamamoto H, Yamaguchi T, Kaida S, Miyake T, Takebayashi K, Kushima R, Tani M. Prognostic impact of CD44-positive cancer stem-like cells at the invasive front of gastric cancer. Br J Cancer. 2017;116(2):186-94.
-
(2017)
Br J Cancer
, vol.116
, Issue.2
, pp. 186-194
-
-
Kodama, H.1
Murata, S.2
Ishida, M.3
Yamamoto, H.4
Yamaguchi, T.5
Kaida, S.6
Miyake, T.7
Takebayashi, K.8
Kushima, R.9
Tani, M.10
-
225
-
-
85026824000
-
Strategies to Inhibit Myc and Their Clinical Applicability
-
28280720 5322154
-
Whitfield JR, Beaulieu ME, Soucek L. Strategies to Inhibit Myc and Their Clinical Applicability. Front Cell Dev Biol. 2017;5:10.
-
(2017)
Front Cell Dev Biol
, vol.5
, pp. 10
-
-
Whitfield, J.R.1
Beaulieu, M.E.2
Soucek, L.3
-
226
-
-
0037096903
-
Omomyc, a potential Myc dominant negative, enhances Myc-induced apoptosis
-
12067996
-
Soucek L, Jucker R, Panacchia L, Ricordy R, Tato F, Nasi S. Omomyc, a potential Myc dominant negative, enhances Myc-induced apoptosis. Cancer Res. 2002;62(12):3507-10.
-
(2002)
Cancer Res
, vol.62
, Issue.12
, pp. 3507-3510
-
-
Soucek, L.1
Jucker, R.2
Panacchia, L.3
Ricordy, R.4
Tato, F.5
Nasi, S.6
-
227
-
-
84991728056
-
OmoMYC blunts promoter invasion by oncogenic MYC to inhibit gene expression characteristic of MYC-dependent tumors
-
27748763
-
Jung LA, Gebhardt A, Koelmel W, Ade CP, Walz S, Kuper J, von Eyss B, Letschert S, Redel C, d'Artista L, et al. OmoMYC blunts promoter invasion by oncogenic MYC to inhibit gene expression characteristic of MYC-dependent tumors. Oncogene. 2017;36(14):1911-1924.
-
(2017)
Oncogene
, vol.36
, Issue.14
, pp. 1911-1924
-
-
Jung, L.A.1
Gebhardt, A.2
Koelmel, W.3
Ade, C.P.4
Walz, S.5
Kuper, J.6
Von Eyss, B.7
Letschert, S.8
Redel, C.9
D'Artista, L.10
-
228
-
-
80052955256
-
BET bromodomain inhibition as a therapeutic strategy to target c-Myc
-
21889194 3187920
-
Delmore JE, Issa GC, Lemieux ME, Rahl PB, Shi J, Jacobs HM, Kastritis E, Gilpatrick T, Paranal RM, Qi J, et al. BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell. 2011;146(6):904-917.
-
(2011)
Cell
, vol.146
, Issue.6
, pp. 904-917
-
-
Delmore, J.E.1
Issa, G.C.2
Lemieux, M.E.3
Rahl, P.B.4
Shi, J.5
Jacobs, H.M.6
Kastritis, E.7
Gilpatrick, T.8
Paranal, R.M.9
Qi, J.10
-
229
-
-
84962683838
-
BET Bromodomain Inhibition Releases the Mediator Complex from Select cis-Regulatory Elements
-
27068464 4838499
-
Bhagwat AS, Roe JS, Mok BYL, Hohmann AF, Shi J, Vakoc CR. BET Bromodomain Inhibition Releases the Mediator Complex from Select cis-Regulatory Elements. Cell Rep. 2016;15(3):519-30.
-
(2016)
Cell Rep
, vol.15
, Issue.3
, pp. 519-530
-
-
Bhagwat, A.S.1
Roe, J.S.2
Mok, B.Y.L.3
Hohmann, A.F.4
Shi, J.5
Vakoc, C.R.6
-
230
-
-
84876222028
-
Selective inhibition of tumor oncogenes by disruption of super-enhancers
-
23582323 3760967
-
Loven J, Hoke HA, Lin CY, Lau A, Orlando DA, Vakoc CR, Bradner JE, Lee TI, Young RA. Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell. 2013;153(2):320-34.
-
(2013)
Cell
, vol.153
, Issue.2
, pp. 320-334
-
-
Loven, J.1
Hoke, H.A.2
Lin, C.Y.3
Lau, A.4
Orlando, D.A.5
Vakoc, C.R.6
Bradner, J.E.7
Lee, T.I.8
Young, R.A.9
-
231
-
-
84943747585
-
Disruption of BRD4 at H3K27Ac-enriched enhancer region correlates with decreased c-Myc expression in Merkel cell carcinoma
-
25941994 4622756
-
Sengupta D, Kannan A, Kern M, Moreno MA, Vural E, Stack B Jr, Suen JY, Tackett AJ, Gao L. Disruption of BRD4 at H3K27Ac-enriched enhancer region correlates with decreased c-Myc expression in Merkel cell carcinoma. Epigenetics. 2015;10(6):460-6.
-
(2015)
Epigenetics
, vol.10
, Issue.6
, pp. 460-466
-
-
Sengupta, D.1
Kannan, A.2
Kern, M.3
Moreno, M.A.4
Vural, E.5
Stack, B.6
Suen, J.Y.7
Tackett, A.J.8
Gao, L.9
-
232
-
-
0031455754
-
Interferon-gamma and retinoic acid down-regulate N-myc in neuroblastoma through complementary mechanisms of action
-
9570357
-
Wada RK, Pai DS, Huang J, Yamashiro JM, Sidell N. Interferon-gamma and retinoic acid down-regulate N-myc in neuroblastoma through complementary mechanisms of action. Cancer Lett. 1997;121(2):181-8.
-
(1997)
Cancer Lett
, vol.121
, Issue.2
, pp. 181-188
-
-
Wada, R.K.1
Pai, D.S.2
Huang, J.3
Yamashiro, J.M.4
Sidell, N.5
-
233
-
-
35148882962
-
A phase 2 trial of all-trans-retinoic acid in combination with interferon-alpha2a in children with recurrent neuroblastoma or Wilms tumor: A Pediatric Oncology Branch, NCI and Children's Oncology Group Study
-
16900483
-
Adamson PC, Matthay KK, O'Brien M, Reaman GH, Sato JK, Balis FM. A phase 2 trial of all-trans-retinoic acid in combination with interferon-alpha2a in children with recurrent neuroblastoma or Wilms tumor: A Pediatric Oncology Branch, NCI and Children's Oncology Group Study. Pediatr Blood Cancer. 2007;49(5):661-5.
-
(2007)
Pediatr Blood Cancer
, vol.49
, Issue.5
, pp. 661-665
-
-
Adamson, P.C.1
Matthay, K.K.2
O'Brien, M.3
Reaman, G.H.4
Sato, J.K.5
Balis, F.M.6
-
234
-
-
37649000950
-
Tumor cell-selective regulation of NOXA by c-MYC in response to proteasome inhibition
-
18042711 2148316
-
Nikiforov MA, Riblett M, Tang WH, Gratchouck V, Zhuang D, Fernandez Y, Verhaegen M, Varambally S, Chinnaiyan AM, Jakubowiak AJ, et al. Tumor cell-selective regulation of NOXA by c-MYC in response to proteasome inhibition. Proc Natl Acad Sci U S A. 2007;104(49):19488-19493.
-
(2007)
Proc Natl Acad Sci U S A
, vol.104
, Issue.49
, pp. 19488-19493
-
-
Nikiforov, M.A.1
Riblett, M.2
Tang, W.H.3
Gratchouck, V.4
Zhuang, D.5
Fernandez, Y.6
Verhaegen, M.7
Varambally, S.8
Chinnaiyan, A.M.9
Jakubowiak, A.J.10
-
235
-
-
84944446748
-
Bortezomib inhibits Burkitt's lymphoma cell proliferation by downregulating sumoylated hnRNP K and c-Myc expression
-
26317903 4694880
-
Suk FM, Lin SY, Lin RJ, Hsine YH, Liao YJ, Fang SU, Liang YC. Bortezomib inhibits Burkitt's lymphoma cell proliferation by downregulating sumoylated hnRNP K and c-Myc expression. Oncotarget. 2015;6(28):25988-6001.
-
(2015)
Oncotarget
, vol.6
, Issue.28
, pp. 25988-26001
-
-
Suk, F.M.1
Lin, S.Y.2
Lin, R.J.3
Hsine, Y.H.4
Liao, Y.J.5
Fang, S.U.6
Liang, Y.C.7
-
236
-
-
85037704971
-
Administering xCT Inhibitors Based on Circadian Clock Improves Antitumor Effects
-
To H 29038345
-
Okazaki F, Matsunaga N, Hamamura K, Suzuki K, Nakao T, Okazaki H, Kutsukake M, Fukumori S, Tsuji Y, To H. Administering xCT Inhibitors Based on Circadian Clock Improves Antitumor Effects. Cancer Res. 2017;77(23):6603-13.
-
(2017)
Cancer Res
, vol.77
, Issue.23
, pp. 6603-6613
-
-
Okazaki, F.1
Matsunaga, N.2
Hamamura, K.3
Suzuki, K.4
Nakao, T.5
Okazaki, H.6
Kutsukake, M.7
Fukumori, S.8
Tsuji, Y.9
|